Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Open in Screener

PLUR

Pluri Inc

Nov 20 • 01:28PM ET

4.05

+0.49 13.60 %

Healthcare • Biotechnology • Israel • NASD

Peers: AAPL GOOGL MSFT AMZN TSLA META NVDA NFLX ORCL INTC

Index	-	P/E	-	EPS (ttm)	-3.08	Insider Own	29.70%	Shs Outstand	8.16M	Perf Week	-3.11%
Market Cap	37.48M	Forward P/E	-	EPS next Y	-	Insider Trans	108.28%	Shs Float	6.51M	Perf Month	4.71%
Enterprise Value	61.95M	PEG	-	EPS next Q	-	Inst Own	14.52%	Short Float	0.27%	Perf Quarter	-28.70%
Income	-22.55M	P/S	28.18	EPS this Y	-	Inst Trans	-0.95%	Short Ratio	0.81	Perf Half Y	-10.20%
Sales	1.33M	P/B	-	EPS next Y	-	ROA	-65.26%	Short Interest	0.02M	Perf YTD	-5.26%
Book/sh	-1.39	P/C	2.42	EPS next 5Y	-	ROE	-1205.58%	52W High	7.13 -43.20%	Perf Year	-25.69%
Cash/sh	1.67	P/FCF	-	EPS past 3/5Y	29.68% 22.58%	ROIC	-	52W Low	3.22 25.78%	Perf 3Y	-31.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	78.73% 125.33%	Gross Margin	14.18%	Volatility	11.90% 8.09%	Perf 5Y	-94.15%
Dividend TTM	-	EV/Sales	46.58	EPS Y/Y TTM	24.75%	Oper. Margin	-1759.28%	ATR (14)	0.38	Perf 10Y	-96.89%
Dividend Ex-Date	-	Quick Ratio	0.53	Sales Y/Y TTM	121.74%	Profit Margin	-1700.68%	RSI (14)	52.15	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.53	EPS Q/Q	39.64%	SMA20	6.61%	Beta	0.58	Target Price	12.00
Payout	-	Debt/Eq	-	Sales Q/Q	-3.07%	SMA50	-3.59%	Rel Volume	5.79	Prev Close	3.57
Employees	127	LT Debt/Eq	-	Earnings	May 08	SMA200	-12.25%	Avg Volume	21.85K	Price	4.05
IPO	Apr 16, 2003	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	80,601	Change	13.60%

Nov-13-25 08:00AM	Pluri and Subsidiaries Earn Multiple Industry Honors, Named as Overall BioAgriculture Company of the Year (GlobeNewswire) -6.07%
Nov-12-25 04:55PM	Pluri: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +7.49%
Nov-11-25 08:00AM	Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare (GlobeNewswire) +6.15%
Nov-10-25 08:00AM	Leading Global Players Back and Fund Pluri's Cell-Based Food and Agriculture Collaborations (GlobeNewswire) +18.54%
Oct-24-25 08:07AM	Pluri Subsidiary Coffeesai Partners with Mexico's INCAFECH to Advance Cell-Based Coffee Manufacturing (Insider Monkey)
09:00AM	Loading…
Oct-08-25 09:00AM	Pluri Subsidiary Coffeesai and Instituto del Cafe de Chiapas Announce Strategic Collaboration to Advance Cell-Based Coffee Manufacturing in Mexico (GlobeNewswire) -5.12%
Aug-14-25 04:30PM	Plurilock Announces Dates for Second Quarter 2025 Financial Results (Newsfile)
May-15-25 07:00AM	Pluri CEO Issues Shareholder Letter Highlighting Strategic Growth, Innovation, and Global Market Expansion (GlobeNewswire)
May-13-25 04:43PM	Pluri: Fiscal Q3 Earnings Snapshot (Associated Press Finance) -9.32%
Apr-28-25 08:00AM	Pluri Completes Strategic Acquisition of Leading Cultivated Cacao AgFoodTech Company, Kokomodo Ltd. (GlobeNewswire) -13.67%
Apr-11-25 10:37AM	Pluris immune cell expansion technologies gain patents (Pharmaceutical Technology)
Apr-10-25 08:30AM	Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel (GlobeNewswire) -6.03%
Mar-05-25 07:00AM	Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness (GlobeNewswire) +5.86%
Feb-19-25 09:01AM	Ever After Foods and Buhler Collaborate to Scale Cultivated Meat Production and Distribution (GlobeNewswire)
09:01AM	Ever After Foods and B hler Collaborate to Scale Cultivated Meat Production and Distribution (GlobeNewswire)
05:37PM	Loading…
Feb-11-25 05:37PM	Pluri: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
Feb-04-25 07:00AM	Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million (GlobeNewswire)
Jan-24-25 09:25AM	Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market (TipRanks)
Jan-23-25 07:15AM	Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition (GlobeNewswire) +6.40%
Dec-19-24 08:00AM	Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease (GlobeNewswire)
Dec-09-24 09:00AM	Pluri Shortlisted for CDMO of the Year Award by Advanced Therapies Awards 2025 (GlobeNewswire)
Dec-03-24 03:45PM	Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing (ACCESS Newswire)
Nov-25-24 08:30AM	Pluri Evaluates Readiness for Mass Production of PLX-R18 for Acute Radiation Syndrome Amid Rising Nuclear Threat Concerns (GlobeNewswire) +7.55%
Nov-12-24 05:52PM	Pluri: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +8.43% +9.22%
01:00PM	Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event (ACCESSWIRE)
Nov-11-24 06:00AM	BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn Phase 3b Trial Manufacturing (PR Newswire) +11.92%
Oct-28-24 07:00AM	Pluri Collaborates with Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors, Supported by Israel Innovation Authority (GlobeNewswire)
Sep-11-24 01:00PM	Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing (ACCESSWIRE)
Jul-18-24 02:30AM	Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates (GlobeNewswire)
Jul-08-24 07:00AM	Pluri Announces 1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply (GlobeNewswire)
06:30AM	Loading…
Jun-18-24 06:30AM	Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges (GlobeNewswire)
Jun-06-24 06:45AM	U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract (GlobeNewswire)
May-20-24 07:00AM	Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale (GlobeNewswire)
May-02-24 07:00AM	Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment (GlobeNewswire) +5.03%
Apr-08-24 07:00AM	Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method (GlobeNewswire)
Apr-03-24 02:52PM	PLUR Stock Earnings: Pluri Reported Results for Q4 2023 (InvestorPlace) -8.70%
Mar-28-24 07:15AM	Pluri's Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences (GlobeNewswire) -8.39%
Mar-27-24 07:00AM	Pluri Inc. Announces 1-for-8 Reverse Share Split (GlobeNewswire) -13.75%
Mar-21-24 07:00AM	Pluri's Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report (GlobeNewswire)
Mar-19-24 04:00AM	Engage with Pluri's Talent: Exciting Conference Appearances Ahead (GlobeNewswire)
Mar-14-24 07:00AM	Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing (GlobeNewswire)
Mar-11-24 07:00AM	Pluri Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation (GlobeNewswire)
Mar-06-24 07:00AM	Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board (GlobeNewswire) +13.77%
Feb-28-24 07:00AM	Pluri's Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals (GlobeNewswire)
Feb-12-24 05:20PM	Pluri: Fiscal Q2 Earnings Snapshot (Associated Press Finance) -7.49%
Jan-23-24 02:00AM	Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis (GlobeNewswire) +15.81%
Jan-08-24 07:00AM	Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization (GlobeNewswire) -6.79%
Dec-21-23 07:00AM	Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction (GlobeNewswire)
Nov-13-23 07:29PM	Pluri: Fiscal Q1 Earnings Snapshot (Associated Press Finance) +5.99%
Aug-16-23 07:00AM	Pluris PLX-R18 Increases Blood Cell Counts and Reduces Need for Transfusions in a Phase I Study: Results Published in Nature Bone Marrow Transplantation (GlobeNewswire)
Jul-13-23 02:00AM	Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of Directors (GlobeNewswire) +5.54%
Jul-12-23 11:17AM	Deutsche Bank Predicts up to 160% Rally for These 3 Stocks Heres Why They Have Solid Upside (TipRanks) -5.25%
Jul-11-23 02:00AM	U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluris PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation Syndrome (GlobeNewswire) +8.91%
Apr-27-23 07:00AM	Cell Manufacturing Pioneer, Pluri Inc., Unveils PluriMatrix: a Breakthrough System for Unprecedented Industrial Scale Production of Cell-Based Products (GlobeNewswire)
Mar-13-23 08:00AM	Israels Ministry of Labor Names Pluri as Winner of the 2022 Egalitarian Employment Award for its Commitment to Gender Diversity and Pay Equity (GlobeNewswire)
Dec-22-22 07:00AM	Pluri CEO Issues Letter to Shareholders Summarizing the Strategy Change and Progress in 2022 and Announcing Food Tech Joint Venture Proof of Concept (GlobeNewswire)
Dec-15-22 04:05PM	Pluri Prices $8.2 million Private Placement Offerings Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) +9.30%
Nov-10-22 07:00AM	Pluri wins BioTech Breakthrough Cell Innovation of the Year Award (GlobeNewswire) +8.10%
Oct-31-22 08:00AM	Pluri to Present and Participate in Upcoming Conferences (GlobeNewswire)
Sep-29-22 07:00AM	Pluri CEO Issues Letter to Shareholders Announcing New Tech Collaboration, Cost Reduction in line with New Strategy and Financial Updates (GlobeNewswire)
Sep-06-22 07:00AM	7.5 Million Granted to Collaborative PROTO Project led by Charité to Study Pluris PLX-PAD Cells for Osteoarthritis Treatment (GlobeNewswire)
Apr-07-22 07:00AM	Plurilock's Aurora Systems Receives US$224,000 Purchase Order from the U.S. Library of Congress (Newsfile)
Apr-01-22 07:00AM	Plurilock Names Garr Stephenson Jr. as Chief Revenue Officer (Newsfile)
Mar-31-22 07:00AM	Plurilock's Aurora Systems Receives US$1.5 Million Purchase Order from the U.S. Department of Defense (Newsfile)
Mar-28-22 07:00AM	Plurilock Submits Non-Provisional U.S. Patent Application for Multi-Device Identity Confirmation Technology (Newsfile)
Mar-23-22 07:00AM	Plurilock's Aurora Systems Receives US$1.85 Million Purchase Order from the U.S. Department of the Navy (Newsfile)
Mar-17-22 07:00AM	Plurilock Adds Brandon Swafford to Advisory Board (Newsfile)

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Manieu Alexandre Weinstein	Director	Oct 29 '25	Option Exercise	0.00	1,002,169	100	1,933,415	Nov 20 11:35 AM
Manieu Alexandre Weinstein	Director	Apr 28 '25	Buy	4.61	452,702	2,086,956	452,702	Nov 20 11:35 AM
Manieu Alexandre Weinstein	Director	Apr 28 '25	Buy	4.61	976,139	4,500,001	931,246	Jul 01 04:00 PM

Open in Screener

TBRG

TruBridge Inc

Nov 20 • 01:33PM ET

21.07

+0.46 2.23 %

Healthcare • Health Information Services • USA • NASD

Peers: OMCL MCK EVH HSTM PINC CNMD TDOC RCM CPSH

| Held by: VTI IWM VXF IWO DFAT SCHA VTWO DFAS PSC PRFZ

Index	RUT	P/E	113.10	EPS (ttm)	0.19	Insider Own	3.56%	Shs Outstand	15.00M	Perf Week	3.18%
Market Cap	316.24M	Forward P/E	9.21	EPS next Y	2.29	Insider Trans	61.60%	Shs Float	14.47M	Perf Month	8.11%
Enterprise Value	463.18M	PEG	0.89	EPS next Q	0.66	Inst Own	81.42%	Short Float	4.77%	Perf Quarter	2.88%
Income	2.78M	P/S	0.91	EPS this Y	908.33%	Inst Trans	2.07%	Short Ratio	7.39	Perf Half Y	-11.06%
Sales	346.40M	P/B	1.75	EPS next Y	-5.49%	ROA	0.69%	Short Interest	0.69M	Perf YTD	6.85%
Book/sh	12.02	P/C	15.88	EPS next 5Y	126.98%	ROE	1.57%	52W High	32.00 -34.16%	Perf Year	31.03%
Cash/sh	1.33	P/FCF	8.50	EPS past 3/5Y	- -	ROIC	0.81%	52W Low	15.69 34.29%	Perf 3Y	-26.59%
Dividend Est.	-	EV/EBITDA	7.91	Sales past 3/5Y	6.88% 4.52%	Gross Margin	45.04%	Volatility	3.98% 3.66%	Perf 5Y	-28.96%
Dividend TTM	-	EV/Sales	1.34	EPS Y/Y TTM	104.56%	Oper. Margin	9.26%	ATR (14)	0.75	Perf 10Y	-47.92%
Dividend Ex-Date	-	Quick Ratio	1.90	Sales Y/Y TTM	3.75%	Profit Margin	0.80%	RSI (14)	64.33	Recom	2.20
Dividend Gr. 3/5Y	- -	Current Ratio	1.91	EPS Q/Q	156.82%	SMA20	6.41%	Beta	0.58	Target Price	22.60
Payout	-	Debt/Eq	0.93	Sales Q/Q	2.72%	SMA50	4.54%	Rel Volume	0.62	Prev Close	20.61
Employees	3200	LT Debt/Eq	0.90	Earnings	Nov 06 AMC	SMA200	-9.16%	Avg Volume	93.39K	Price	21.07
IPO	May 21, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	49.03% -5.71%	Trades		Volume	37,239	Change	2.23%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$19.50
Mar-28-24	Initiated	RBC Capital Mkts	Outperform	$13
Jan-03-24	Initiated	Barclays	Equal Weight	$12
Aug-15-23	Initiated	Cantor Fitzgerald	Overweight	$24
Apr-12-23	Initiated	Stephens	Equal-Weight	$30
Sep-10-20	Upgrade	KeyBanc Capital Markets	Underweight → Sector Weight
May-08-20	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$27
Apr-13-20	Initiated	SVB Leerink	Outperform
Sep-26-19	Initiated	Deutsche Bank	Hold	$24
Sep-10-19	Upgrade	Dougherty & Company	Neutral → Buy	$26
Aug-07-19	Downgrade	Dougherty & Company	Buy → Neutral
May-07-19	Upgrade	Wells Fargo	Market Perform → Outperform
May-03-19	Reiterated	Dougherty & Company	Buy	$38 → $33
May-08-17	Reiterated	Dougherty & Company	Buy	$32 → $36
Feb-27-17	Reiterated	Dougherty & Company	Buy	$30 → $31
Jan-19-17	Initiated	Dougherty & Company	Buy	$29
Aug-05-16	Reiterated	FBR Capital	Mkt Perform	$48 → $30
May-11-16	Reiterated	RBC Capital Mkts	Sector Perform	$55 → $47
May-05-16	Reiterated	Topeka Capital Markets	Buy	$61 → $62
Apr-14-16	Downgrade	Robert W. Baird	Outperform → Neutral	$65 → $59

Show Previous Ratings

Nov-14-25 08:02PM	TruBridge Inc (TBRG) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Shifts ... (GuruFocus.com)
Nov-06-25 06:05PM	TruBridge (TBRG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
05:03PM	TruBridge: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	TruBridge Announces Third Quarter 2025 Results (Business Wire)
Oct-31-25 11:00AM	TruBridge Announces Third Quarter 2025 Conference Call to Be Held Friday, November 7, 2025 (Business Wire)
09:15AM	Loading…
Oct-03-25 09:15AM	TruBridge Names Michael Daughton as Chief Business Officer to Advance Mission of Strengthening Rural and Community Healthcare (Business Wire)
Sep-28-25 04:19PM	TruBridge, Inc. (TBRG): A Bull Case Theory (Insider Monkey)
Sep-24-25 09:39AM	Java Medical Group expands TruBridge services at Russellville Hospital (Hospital Management)
Sep-23-25 09:00AM	Java Medical Group Expands Partnership With TruBridge for EHR, Financial Health Technology, and Services (Business Wire)
Aug-08-25 05:06AM	TruBridge: Q2 Earnings Snapshot (Associated Press Finance) -10.76%
Aug-07-25 08:10PM	TruBridge Announces Second Quarter 2025 Results (Business Wire)
Aug-05-25 07:26AM	Jackson Parish Hospital teams up with TruBridge to support financial operations (Hospital Management)
Aug-04-25 08:00AM	TruBridge Re-Establishes Partnership With Jackson Parish Hospital to Boost Financial Performance and Outcomes (Business Wire)
Aug-01-25 12:00PM	TruBridge Announces Second Quarter 2025 Conference Call to Be Held Friday, August 8, 2025 (Business Wire)
Jul-30-25 04:45PM	TruBridge Champions Rural and Community Health in National Interoperability Initiative (Business Wire)
08:00AM	Loading…
Jun-10-25 08:00AM	TruBridge Announces Participation in the Truist Securities Healthcare Disruptors & Digital Health Conference (Business Wire)
May-19-25 09:00AM	TruBridge Announces Next Step of Collaboration With Microsoft, Enhancing Community Healthcare Through Advanced Clinical Documentation Capabilities (Business Wire)
May-13-25 06:22AM	New Strong Buy Stocks for May 13th (Zacks) -5.02%
May-08-25 02:30PM	TruBridge Announces Participation in the RBC Global Healthcare Conference (Business Wire)
May-07-25 07:05PM	TruBridge (TBRG) Lags Q1 Earnings Estimates (Zacks)
04:05PM	TruBridge Announces First Quarter 2025 Results (Business Wire)
May-01-25 11:00AM	TruBridge Announces First Quarter 2025 Conference Call to Be Held Wednesday, May 7, 2025 (Business Wire)
Apr-23-25 08:54AM	Do Options Traders Know Something About TruBridge Stock We Don't? (Zacks)
Apr-14-25 04:18AM	Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last? (Zacks)
Apr-13-25 10:44AM	The 1-Minute Market Report April 13, 2025 (Seeking Alpha)
Mar-31-25 08:05AM	The 1-Minute Market Report March 30, 2025 (Seeking Alpha)
Mar-14-25 12:45PM	TruBridge Announces Participation in the KeyBanc Capital Markets Healthcare Forum (Business Wire)
Mar-11-25 03:02AM	TruBridge Inc (TBRG) Q4 2024 Earnings Call Highlights: Strong EBITDA Growth and Improved ... (GuruFocus.com) +7.49%
Mar-10-25 04:05PM	TruBridge Announces Fourth Quarter and Full Year 2024 Results and Provides Initial 2025 Outlook (Business Wire)
Feb-28-25 01:00PM	TruBridge Announces Fourth Quarter and Year-End 2024 Conference Call to Be Held Monday, March 10, 2025 (Business Wire)
10:05AM	Loading…
Feb-13-25 10:05AM	TruBridge selected as preferred partner by Cibolo Health (TipRanks) +5.51%
Feb-12-25 10:00AM	TruBridge Selected by Cibolo Health as a Preferred Partner for RCM Technology and Services (Business Wire)
Feb-11-25 08:00AM	TruBridge Announces Two Directors to Join Its Board as a Part of Cooperation Agreements With Pinetree Capital and Ocho Investments (Business Wire) +6.43%
Jan-30-25 10:00AM	TruBridge Chosen by Lady of the Sea General Hospital as Advanced Technology Partner (Business Wire)
Jan-02-25 12:00PM	TruBridge Names Merideth Wilson as Financial Health General Manager (Business Wire)
Nov-12-24 02:00PM	TruBridge to Participate in Stephens 2024 Annual Investment Conference (Business Wire) +9.22%
Nov-09-24 02:06AM	TruBridge Inc (TBRG) Q3 2024 Earnings Call Highlights: Strong Bookings and Financial Health ... (GuruFocus.com)
Nov-07-24 05:00PM	TruBridge Announces Third Quarter 2024 Results (Business Wire)
Oct-29-24 12:00PM	TruBridge Announces Third Quarter 2024 Conference Call to Be Held Friday, November 8, 2024 (Business Wire)
Oct-21-24 02:00PM	TruBridge Elects Amy OKeefe to the Companys Board of Directors (Business Wire)
Aug-08-24 04:05PM	TruBridge Announces Second Quarter 2024 Results (Business Wire) +24.46%
Jul-25-24 11:00AM	TruBridge Announces Date for Second Quarter 2024 Conference Call (Business Wire)
Jul-16-24 11:00AM	TruBridge Achieves Consecutive Year HFMA Peer Reviewed Status for Complete Business Office and Revenue Cycle Management Solutions (Business Wire)
Jun-28-24 12:00PM	TruBridge Ranked as a Top Provider by Black Book in Its 2024 Report of Top Client-Rated Financial and RCM Solutions (Business Wire)
May-24-24 11:00AM	TruBridge Announces Participation in the Stifel Cross Sector Insight Conference (Business Wire)
May-23-24 03:28PM	TruBridge Awarded Peer Review Designation by Healthcare Financial Management Association (Business Wire) +5.51%
May-10-24 03:53PM	TruBridge Inc (TBRG) Q1 2024 Earnings: Navigating Through Transformation and Market Challenges (GuruFocus.com)
11:53AM	TBRG Stock Earnings: TruBridge Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
08:10AM	TruBridge (TBRG) Q1 Earnings Miss Estimates (Zacks)
07:00AM	TruBridge Announces First Quarter 2024 Results (Business Wire)
May-08-24 12:00PM	TruBridge and Multiview Announce Preferred Partnership Making Enhanced Financial Management Solutions Available to TruBridge Clients (Business Wire)
11:00AM	TruBridge Announces Participation in 2024 RBC Capital Markets Global Healthcare Conference (Business Wire)
May-06-24 03:30PM	TruBridge to Webcast Its First Quarter 2024 Conference Call (Business Wire)
Apr-29-24 10:00AM	Dr. David Rhew, Global Chief Medical Officer & Vice President of Healthcare at Microsoft, to Address Rural and Community Healthcare Professionals at TruBridge National Client Conference (Business Wire)
Apr-23-24 08:00AM	TruBridge Amends Limited Duration Stockholder Rights Plan, Increasing Threshold To 15% (Business Wire)
Apr-11-24 05:36AM	TruBridge (TBRG): Cove Street Capital's New Addition (Insider Monkey)
Mar-26-24 08:00AM	TruBridge Announces Adoption of Limited Duration Stockholder Rights Plan (Business Wire)
Mar-17-24 08:42AM	50 Biggest Countries on Earth by Area (Insider Monkey)
Mar-05-24 11:00AM	TruBridge Announces Participation in Barclays 26th Annual Global Healthcare Conference (Business Wire)
Mar-04-24 08:00AM	CPSI, Rebranded as TruBridge, Inc., Rings Opening Bell at NASDAQ to Announce New Trading Symbol TBRG (Business Wire) -16.54%
Mar-02-24 08:13AM	Computer Programs and Systems, Inc. (NASDAQ:CPSI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 06:39AM	Q4 2023 Computer Programs and Systems Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-29-24 05:55PM	Computer Programs and Systems (CPSI) Q4 Earnings and Revenues Surpass Estimates (Zacks)
04:56PM	Computer Programs and Systems: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	CPSI Announces Fourth Quarter and Full Year 2023 Results (Business Wire)
Feb-22-24 03:00PM	CPSI to Webcast Its Fourth Quarter and Year-End 2023 Conference Call (Business Wire) -8.92%
10:45AM	CPSI to Rebrand as TruBridge, Inc. (Business Wire)
Jan-17-24 09:05AM	CPSI and PointClickCare Announce Exclusive Referral Partnership for TruBridge RCM Services to Skilled Nursing Facilities (Business Wire)
09:00AM	CPSI Announces Divestment of American HealthTech to PointClickCare (Business Wire)
Nov-10-23 10:16AM	Computer Programs and Systems, Inc. (NASDAQ:CPSI) Q3 2023 Earnings Call Transcript (Insider Monkey) -6.34%
Nov-09-23 11:00AM	CPSI to Participate in Stephens 2023 Annual Investment Conference (Business Wire) -11.46%
09:10AM	Q3 2023 Computer Programs and Systems Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 06:15PM	Computer Programs and Systems (CPSI) Q3 Earnings Beat Estimates (Zacks)
05:13PM	Computer Programs and Systems: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CPSI Announces Third Quarter 2023 Results (Business Wire)
Nov-07-23 04:05PM	CPSI Appoints Vinay Bassi as New Chief Financial Officer (Business Wire)
Oct-25-23 11:00AM	CPSI to Webcast Its Third Quarter 2023 Conference Call (Business Wire)
Oct-16-23 04:05PM	CPSI Acquires Viewgol and Accelerates Global Workforce Presence (Business Wire)
Oct-04-23 08:00AM	TruCode Exhibiting at AHIMA Under New Name, Showcasing Their Cloud-Based Medical Coding Technology, TruBridge Encoder (Business Wire) +5.57%
Sep-11-23 03:00PM	CPSI Announces Participation in Cantor Global Healthcare Conference 2023 (Business Wire)
Sep-01-23 06:51PM	Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
Aug-15-23 09:59AM	Redfin upgraded, CSSE downgraded: Wall Street's top analyst calls (The Fly)
Aug-11-23 10:34AM	Computer Programs and Systems, Inc. (NASDAQ:CPSI) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 06:00AM	Q2 2023 Computer Programs and Systems Inc Earnings Call (Thomson Reuters StreetEvents) -19.66%
Aug-09-23 06:30PM	Computer Programs and Systems (CPSI) Lags Q2 Earnings and Revenue Estimates (Zacks)
05:21PM	Computer Programs and Systems: Q2 Earnings Snapshot (AP Finance)
04:05PM	CPSI Announces Second Quarter 2023 Results (Business Wire)
Jul-31-23 12:30PM	CPSI Names Mark V. Anquillare to Board of Directors (Business Wire)
Jul-26-23 11:00AM	CPSI to Webcast Its Second Quarter 2023 Conference Call (Business Wire)
Jul-06-23 07:11AM	The past five years for Computer Programs and Systems (NASDAQ:CPSI) investors has not been profitable (Simply Wall St.)
Jun-21-23 08:00PM	CPSI: Lowering target price to $26.00 (Argus Research)
Jun-05-23 12:30PM	CPSI Announces Participation in Stifel 2023 Cross Sector Insight Conference (Business Wire)
May-14-23 08:26AM	Here's What's Concerning About Computer Programs and Systems' (NASDAQ:CPSI) Returns On Capital (Simply Wall St.)
May-09-23 10:07PM	Q1 2023 Computer Programs and Systems Inc Earnings Call (Thomson Reuters StreetEvents) -10.85%
08:45AM	Computer Programs and Systems (CPSI) Misses Q1 Earnings Estimates (Zacks)
07:41AM	Computer Programs and Systems: Q1 Earnings Snapshot (AP Finance)
07:30AM	CPSI Announces First Quarter 2023 Results (Business Wire)
Apr-26-23 08:00PM	CPSI: Rating decreased to a HOLD (Argus Research)
Apr-25-23 11:00AM	CPSI to Webcast Its First Quarter 2023 Conference Call (Business Wire)
Apr-12-23 11:34AM	Calculating The Fair Value Of Computer Programs and Systems, Inc. (NASDAQ:CPSI) (Simply Wall St.)

TruBridge, Inc. provides healthcare information technology solutions and services. It operates through the Financial Health and Patient Care segments. The Financial Health segment offers business, consulting, and IT services along with Revenue Cycle Management (RCM) solutions for healthcare providers. The Patient Care segment provides comprehensive acute care Electronic Health Record (EHR) solutions and related services for hospitals and their physician clinics. The company was founded by Michael Kenny Muscat Sr. in 1979 and is headquartered in Mobile, AL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Pinetree Capital Ltd.	10% Owner	Nov 17 '25	Buy	20.42	20,707	422,837	837,860	Nov 19 04:52 PM
Pinetree Capital Ltd.	10% Owner	Nov 19 '25	Buy	20.70	8,501	175,971	850,000	Nov 19 04:52 PM
Pinetree Capital Ltd.	10% Owner	Nov 18 '25	Buy	20.84	3,639	75,837	841,499	Nov 19 04:52 PM
Daughton Michael	Chief Business Officer	Nov 17 '25	Buy	20.46	17,500	358,050	57,492	Nov 18 09:57 AM
Daughton Michael	Chief Business Officer	Nov 11 '25	Buy	19.39	15,479	300,138	22,971	Nov 18 09:57 AM
Daughton Michael	Chief Business Officer	Nov 12 '25	Buy	19.95	10,167	202,832	33,138	Nov 18 09:57 AM
Daughton Michael	Chief Business Officer	Nov 13 '25	Buy	20.16	4,354	87,777	37,492	Nov 18 09:57 AM
Daughton Michael	Chief Business Officer	Nov 14 '25	Buy	20.15	2,500	50,375	39,992	Nov 18 09:57 AM
Pinetree Capital Ltd.	10% Owner	Nov 13 '25	Buy	20.41	21,035	429,324	798,220	Nov 14 06:45 PM
Pinetree Capital Ltd.	10% Owner	Nov 14 '25	Buy	20.23	18,933	383,015	817,153	Nov 14 06:45 PM
Pinetree Capital Ltd.	10% Owner	Nov 12 '25	Buy	19.94	8,935	178,164	777,185	Nov 14 06:45 PM
Harse David	General Manager Patient Care	Mar 14 '25	Sale	27.40	1,744	47,786	18,058	Aug 15 01:39 PM
MacIntyre Vita	Controller	May 20 '25	Sale	24.94	335	8,355	2,090	Jul 28 05:45 PM
L6 Holdings Inc.	10% Owner	May 21 '25	Buy	24.30	40,000	972,000	1,965,000	May 23 05:19 PM
L6 Holdings Inc.	10% Owner	May 23 '25	Buy	24.01	25,000	600,250	2,005,000	May 23 05:19 PM
L6 Holdings Inc.	10% Owner	May 22 '25	Buy	23.98	15,000	359,700	1,980,000	May 23 05:19 PM
Fowler Christopher L	President and CEO	May 16 '25	Sale	25.05	6,000	150,300	131,090	May 20 05:33 PM
MacIntyre Vita	Officer	May 20 '25	Proposed Sale	24.94	335	8,356		May 20 04:00 PM
Fowler Christopher L	Officer	May 16 '25	Proposed Sale	25.05	6,000	150,295		May 16 05:30 PM
L6 Holdings Inc.	10% Owner	Mar 19 '25	Buy	26.93	65,524	1,764,561	1,893,917	Mar 21 04:52 PM
L6 Holdings Inc.	10% Owner	Mar 21 '25	Buy	27.99	31,083	870,013	1,925,000	Mar 21 04:52 PM
Fowler Christopher L	President and CEO	Mar 14 '25	Sale	27.02	5,100	137,802	142,939	Mar 17 06:42 PM
Cronkite Wes	Officer	Mar 14 '25	Proposed Sale	26.89	15,000	403,394		Mar 14 04:33 PM
Harse David	Officer	Mar 14 '25	Proposed Sale	27.40	1,744	47,786		Mar 14 02:57 PM
Fowler Christopher L	Officer	Mar 13 '25	Proposed Sale	27.77	5,100	141,627		Mar 13 02:17 PM
L6 Holdings Inc.	10% Owner	Feb 25 '25	Buy	28.09	87,232	2,450,347	1,828,393	Feb 26 05:21 PM
L6 Holdings Inc.	10% Owner	Feb 24 '25	Buy	28.28	30,377	859,062	1,741,161	Feb 26 05:21 PM
Pinetree Capital Ltd.	10% Owner	Feb 21 '25	Buy	28.25	85,784	2,423,252	1,710,784	Feb 21 05:37 PM
Pinetree Capital Ltd.	10% Owner	Feb 20 '25	Buy	27.99	34,952	978,478	768,250	Feb 21 05:37 PM
Pinetree Capital Ltd.	10% Owner	Feb 19 '25	Buy	28.00	4,122	115,414	733,298	Feb 21 05:37 PM
Pinetree Capital Ltd.	10% Owner	Feb 13 '25	Buy	27.61	74,981	2,070,578	693,981	Feb 18 05:52 PM
Pinetree Capital Ltd.	10% Owner	Feb 14 '25	Buy	27.99	28,400	794,856	722,381	Feb 18 05:52 PM
Pinetree Capital Ltd.	10% Owner	Feb 18 '25	Buy	28.16	6,795	191,368	729,176	Feb 18 05:52 PM
Anquillare Mark V	Director	Nov 25 '24	Buy	16.81	2,500	42,025	17,178	Nov 25 03:39 PM

Open in Screener

DGICA

Donegal Group Inc

Nov 20 • 01:33PM ET

19.36

-0.17 -0.84 %

Financial • Insurance - Property & Casualty • USA • NASD

DGICA Donegal Group Inc daily Stock Chart

Peers: PGR TRV CINF ALL HIG SIGI AFG KMPR WRB THG

| Held by: VTI IWM SMDV AVUV VXF DFAT IWN FSMD DFSV BSVO

Index	RUT	P/E	7.98	EPS (ttm)	2.43	Insider Own	53.53%	Shs Outstand	31.03M	Perf Week	-2.64%
Market Cap	690.27M	Forward P/E	9.76	EPS next Y	1.98	Insider Trans	1.34%	Shs Float	16.77M	Perf Month	0.13%
Enterprise Value	-	PEG	0.57	EPS next Q	0.44	Inst Own	36.30%	Short Float	3.17%	Perf Quarter	10.09%
Income	86.15M	P/S	0.70	EPS this Y	49.03%	Inst Trans	-	Short Ratio	4.08	Perf Half Y	-2.59%
Sales	988.19M	P/B	1.11	EPS next Y	-5.54%	ROA	4.83%	Short Interest	0.53M	Perf YTD	25.18%
Book/sh	17.40	P/C	-	EPS next 5Y	13.89%	ROE	15.10%	52W High	21.12 -8.31%	Perf Year	23.50%
Cash/sh	-	P/FCF	7.81	EPS past 3/5Y	22.75% -1.76%	ROIC	13.01%	52W Low	14.17 36.66%	Perf 3Y	26.40%
Dividend Est.	0.71 (3.68%)	EV/EBITDA	-	Sales past 3/5Y	6.62% 4.03%	Gross Margin	-	Volatility	2.28% 2.36%	Perf 5Y	34.11%
Dividend TTM	0.72 (3.71%)	EV/Sales	-	EPS Y/Y TTM	224.95%	Oper. Margin	10.89%	ATR (14)	0.44	Perf 10Y	39.12%
Dividend Ex-Date	Nov 03, 2025	Quick Ratio	-	Sales Y/Y TTM	0.93%	Profit Margin	8.72%	RSI (14)	50.17	Recom	2.33
Dividend Gr. 3/5Y	2.54% 3.53%	Current Ratio	0.48	EPS Q/Q	8.77%	SMA20	0.51%	Beta	0.01	Target Price	21.00
Payout	45.13%	Debt/Eq	0.06	Sales Q/Q	-2.31%	SMA50	0.48%	Rel Volume	0.79	Prev Close	19.53
Employees	851	LT Debt/Eq	0.06	Earnings	Oct 30 BMO	SMA200	4.04%	Avg Volume	130.31K	Price	19.36
IPO	Apr 24, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.46% -5.57%	Trades		Volume	66,493	Change	-0.84%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-02-25	Upgrade	Janney	Neutral → Buy
Dec-20-23	Initiated	Janney	Neutral	$15
Nov-16-21	Downgrade	Keefe Bruyette	Outperform → Mkt Perform
Nov-01-17	Upgrade	Keefe Bruyette	Mkt Perform → Outperform
Oct-31-17	Upgrade	Boenning & Scattergood	Neutral → Outperform
May-25-17	Initiated	Boenning & Scattergood	Neutral
Dec-20-16	Downgrade	Keefe Bruyette	Outperform → Mkt Perform

Nov-10-25 09:15AM	Heritage Insurance Holdings, Inc. (HRTG) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-05-25 09:40AM	Has Donegal Group (DGICA) Outpaced Other Finance Stocks This Year? (Zacks)
09:40AM	Are Investors Undervaluing Donegal Group (DGICA) Right Now? (Zacks)
Nov-04-25 08:12PM	Donegal Group Inc (DGICA) Q3 2025 Earnings Call Highlights: Strong Underwriting Performance ... (GuruFocus.com)
Oct-30-25 06:45AM	Donegal: Q3 Earnings Snapshot (Associated Press Finance)
06:30AM	Loading…
06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2025 Results (GlobeNewswire)
Oct-29-25 09:51AM	Donegal Group Inc (DGICA) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-20-25 09:40AM	Is Donegal Group (DGICA) Stock Undervalued Right Now? (Zacks)
Oct-16-25 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-15-25 10:30AM	Heritage Insurance (HRTG) Moves 10.6% Higher: Will This Strength Last? (Zacks)
09:35AM	Progressive (PGR) Lags Q3 Earnings and Revenue Estimates (Zacks)
Oct-06-25 12:56PM	Donegal Group Inc. Announces Release Date for Third Quarter 2025 Results (GlobeNewswire)
Oct-02-25 09:40AM	Should Value Investors Buy Donegal Group (DGICA) Stock? (Zacks)
Sep-16-25 09:40AM	Are Investors Undervaluing Donegal Group (DGICA) Right Now? (Zacks)
Sep-15-25 09:15AM	United Fire Group, Inc (UFCS) Hit a 52 Week High, Can the Run Continue? (Zacks)
04:59PM	Loading…
Sep-08-25 04:59PM	Is CNA Financial (CNA) Stock Undervalued Right Now? (Zacks)
Sep-04-25 09:28AM	Best Value Stocks to Buy for September 4th (Zacks) +5.87%
Jul-25-25 07:02AM	Donegal: Q2 Earnings Snapshot (Associated Press Finance)
Jul-24-25 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2025 Results (GlobeNewswire) -6.16%
Jul-23-25 09:59AM	Earnings To Watch: Donegal Group Inc (DGICA) Reports Q2 2025 Result (GuruFocus.com)
Jul-17-25 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jul-02-25 03:00PM	Donegal Group Inc. Announces Release Date for Second Quarter 2025 Results (GlobeNewswire)
Apr-26-25 01:53AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 27 (Seeking Alpha)
Apr-25-25 11:09AM	Donegal Group Inc. (DGICA) Q1 2025 Earnings Call Transcript (Seeking Alpha)
Apr-24-25 06:30AM	Donegal Group Inc. Announces First Quarter 2025 Results (GlobeNewswire) +5.39%
Apr-19-25 01:25AM	Dividend Champion, Contender, And Challenger Highlights: Week Of April 20 (Seeking Alpha)
Apr-17-25 10:00AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Apr-02-25 10:00AM	Donegal Group Inc. Announces Release Date for First Quarter 2025 Results (GlobeNewswire)
Mar-23-25 07:41AM	Is Donegal Group (DGICA) The Stock With The Most Insider Sales In The Last Quarter? (InsiderMonkey)
Feb-20-25 06:30AM	Donegal Group Inc. Announces Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
01:00PM	Loading…
Feb-03-25 01:00PM	Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2024 Results (GlobeNewswire)
Dec-19-24 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-24-24 06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2024 Results (GlobeNewswire) +8.60%
Oct-17-24 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-01-24 03:00PM	Donegal Group Inc. Announces Release Date for Third Quarter 2024 Results (GlobeNewswire)
Sep-25-24 08:05AM	Genpact and Donegal Insurance Group to Elevate Commercial Lines Underwriting Efficiency with Guidewire Solutions (PR Newswire)
Jul-25-24 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2024 Results (GlobeNewswire) +5.63%
Jul-18-24 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jul-01-24 09:00AM	Donegal Group Inc. Announces Release Date for Second Quarter 2024 Results (GlobeNewswire)
May-02-24 01:16PM	AM Best Affirms Credit Ratings of Donegal Insurance Group Members and Donegal Group Inc. (Business Wire)
Apr-25-24 07:45AM	Donegal Group (DGICA) Lags Q1 Earnings Estimates (Zacks)
06:30AM	Donegal Group Inc. Announces First Quarter 2024 Results (GlobeNewswire)
Apr-18-24 10:20AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Apr-02-24 01:00PM	Donegal Group Inc. Announces Release Date for First Quarter 2024 Results (GlobeNewswire)
Feb-22-24 06:30AM	Donegal Group Inc. Announces Fourth Quarter and Full Year 2023 Results (GlobeNewswire)
Feb-01-24 08:30AM	Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2023 Results (GlobeNewswire)
Jan-02-24 09:30AM	Donegal Insurance Group Names Two to Posts of Chief Operating Officer, SVP of Field Operations & National Accounts (GlobeNewswire)
Dec-21-23 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-28-23 12:44PM	Donegal Group Inc. (NASDAQ:DGICA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2023 Results (GlobeNewswire)
Oct-19-23 03:30PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Sep-27-23 08:00AM	Donegal Group Inc. Announces Release Date for Third Quarter 2023 Results (GlobeNewswire)
Jul-27-23 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2023 Results (GlobeNewswire)
Jul-20-23 04:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jun-27-23 11:00AM	Donegal Group Inc. Announces Release Date for Second Quarter 2023 Results (GlobeNewswire)
Apr-27-23 06:30AM	Donegal Group Inc. Announces First Quarter 2023 Results (GlobeNewswire)
Apr-20-23 10:15AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Mar-28-23 03:00PM	Donegal Group Inc. Announces Release Date for First Quarter 2023 Results (GlobeNewswire)
Feb-23-23 06:30AM	Donegal Group Inc. Announces Fourth Quarter and Full Year 2022 Results (GlobeNewswire)
Jan-23-23 01:00PM	Donegal Group Inc. Announces Release Date for Fourth Quarter and Full-Year 2022 Results (GlobeNewswire)
Dec-15-22 03:58PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Nov-21-22 08:14AM	One Donegal Group Inc. (NASDAQ:DGIC.A) insider upped their stake by 5.3% in the previous year (Simply Wall St.)
Oct-27-22 06:30AM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2022 Results (GlobeNewswire)
Oct-25-22 07:34AM	Donegal Group Inc.'s (NASDAQ:DGIC.A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Oct-20-22 02:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Sep-28-22 01:00PM	Donegal Group Inc. Announces Release Date for Third Quarter 2022 Results (GlobeNewswire)
Aug-22-22 06:12AM	Investors in Donegal Group (NASDAQ:DGIC.A) have made a return of 27% over the past three years (Simply Wall St.)
Jul-28-22 06:30AM	Donegal Group Inc. Announces Second Quarter and First Half 2022 Results (GlobeNewswire) -10.23%
Jul-21-22 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Jul-04-22 12:06PM	What Type Of Shareholders Own The Most Number of Donegal Group Inc. (NASDAQ:DGIC.A) Shares? (Simply Wall St.)
Jun-29-22 08:00AM	Donegal Insurance Group Taps David Sponic to Lead Personal Lines Division (GlobeNewswire)
Jun-28-22 08:30AM	Donegal Group Inc. Announces Release Date for Second Quarter 2022 Results (GlobeNewswire)
Jun-05-22 10:25AM	Quite a few insiders invested in Donegal Group Inc. (NASDAQ:DGIC.A) last year which is positive news for shareholders (Simply Wall St.)
May-18-22 06:31AM	Is Donegal Group Inc.'s (NASDAQ:DGIC.A) Recent Stock Performance Influenced By Its Fundamentals In Any Way? (Simply Wall St.)
Apr-28-22 07:55AM	Donegal Group (DGICA) Q1 Earnings Beat Estimates (Zacks)
06:30AM	Donegal Group Inc. Announces First Quarter 2022 Results (GlobeNewswire)
Apr-25-22 06:04AM	Donegal Group's (NASDAQ:DGIC.A) Dividend Will Be Increased To US$0.17 (Simply Wall St.)
Apr-21-22 03:01PM	Earnings Preview: Donegal Group (DGICA) Q1 Earnings Expected to Decline (Zacks)
10:00AM	Donegal Group Inc. Announces Increase in Quarterly Dividend (GlobeNewswire)
Apr-18-22 09:16AM	Donegal Insurance Group Names Hudnall as New SVP of Commercial Lines (GlobeNewswire)
Mar-31-22 04:30PM	Donegal Group Inc. Announces Release Date for First Quarter 2022 Results (GlobeNewswire)
09:47AM	AM Best Affirms Credit Ratings for Members of Donegal Insurance Group and Donegal Group Inc. (Business Wire)
Mar-15-22 07:37AM	Shareholders in Donegal Group (NASDAQ:DGIC.A) are in the red if they invested five years ago (Simply Wall St.)
Feb-17-22 05:25PM	Donegal Group (DGICA) Lags Q4 Earnings and Revenue Estimates (Zacks)
04:05PM	Donegal Group Inc. Announces 2021 Fourth Quarter and Full Year Results (GlobeNewswire)
Feb-10-22 03:01PM	Analysts Estimate Donegal Group (DGICA) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jan-25-22 06:28AM	Do Institutions Own Donegal Group Inc. (NASDAQ:DGIC.A) Shares? (Simply Wall St.)
Jan-20-22 03:30PM	Donegal Group Inc. Announces Fourth Quarter 2021 Conference Call and Webcast (GlobeNewswire)
Dec-17-21 05:54AM	Multiple insiders bought Donegal Group Inc. (NASDAQ:DGIC.A) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Dec-16-21 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-28-21 08:31PM	Donegal Group, inc (DGICA) Q3 2021 Earnings Call Transcript (Motley Fool)
Oct-27-21 05:45PM	Donegal Group (DGICA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Donegal Group Inc. Announces Third Quarter and First Nine Months of 2021 Results (GlobeNewswire)
Oct-25-21 06:44AM	Why You Might Be Interested In Donegal Group Inc. (NASDAQ:DGIC.A) For Its Upcoming Dividend (Simply Wall St.)
Oct-21-21 03:00PM	Donegal Group Inc. Announces Quarterly Dividend (GlobeNewswire)
Oct-09-21 09:59AM	Has Donegal Group Inc. (NASDAQ:DGIC.A) Stock's Recent Performance Got Anything to Do With Its Financial Health? (Simply Wall St.)
Sep-28-21 09:00AM	Donegal Group Inc. Announces Third Quarter 2021 Conference Call and Webcast (GlobeNewswire)
Aug-31-21 07:24AM	I Built A List Of Growing Companies And Donegal Group (NASDAQ:DGIC.A) Made The Cut (Simply Wall St.)
Jul-29-21 04:02AM	Donegal Group, inc (DGICA) Q2 2021 Earnings Call Transcript (Motley Fool)
Jul-27-21 05:45PM	Donegal Group (DGICA) Q2 Earnings Surpass Estimates (Zacks)

Donegal Group, Inc. is an insurance holding company, which engages in the provision of property and casualty insurance to businesses and individuals. It operates through the following segments: Investment Function, Personal Lines of Insurance, and Commercial Lines of Insurance. The Investment Function segment covers investment activities. The Personal Lines of Insurance segment consists of homeowners and private passenger automobile policies. The Commercial Lines of Insurance segment includes commercial automobile, commercial multi-peril, and workers compensation policies. The company was founded on August 26, 1986 and is headquartered in Marietta, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 19 '25	Buy	19.62	7,587	148,845	13,768,361	Nov 20 09:18 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 18 '25	Buy	19.84	7,104	140,953	13,760,774	Nov 20 09:18 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 14 '25	Buy	19.92	8,000	159,357	13,745,670	Nov 18 08:39 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 17 '25	Buy	19.91	8,000	159,262	13,753,670	Nov 18 08:39 AM
SZADY ANNETTE BROOKENS	Director	Nov 13 '25	Option Exercise	14.43	4,500	64,935	7,000	Nov 14 09:53 AM
SZADY ANNETTE BROOKENS	Director	Nov 13 '25	Sale	19.73	4,500	88,767	2,500	Nov 14 09:53 AM
HECKER RICK JOSEPH	SVP & GENERAL COUNSEL	Nov 13 '25	Option Exercise	14.43	900	12,987	900	Nov 14 09:48 AM
HECKER RICK JOSEPH	SVP & GENERAL COUNSEL	Nov 13 '25	Sale	19.74	900	17,762	0	Nov 14 09:48 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 13 '25	Option Exercise	15.05	9,617	144,728	105,001	Nov 14 09:43 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 12 '25	Option Exercise	14.03	8,383	117,592	103,767	Nov 14 09:43 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 13 '25	Sale	19.76	9,617	190,013	95,384	Nov 14 09:43 AM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 12 '25	Sale	19.77	8,383	165,698	95,384	Nov 14 09:43 AM
Moore Sewell Trezevant Jr	Director	Nov 13 '25	Option Exercise	14.43	4,500	64,935	30,655	Nov 14 09:35 AM
Moore Sewell Trezevant Jr	Director	Nov 13 '25	Sale	19.70	4,500	88,671	26,155	Nov 14 09:35 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 13 '25	Buy	19.53	29,000	566,300	13,737,670	Nov 14 09:26 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 12 '25	Buy	19.74	6,794	134,107	13,708,670	Nov 14 09:26 AM
SZADY ANNETTE BROOKENS	Director	Nov 13 '25	Proposed Sale	19.77	4,500	88,965		Nov 13 10:31 AM
Moore Sewell Trezevant Jr	Director	Nov 12 '25	Proposed Sale	19.71	4,500	88,695		Nov 12 03:02 PM
WAGNER DANIEL J	Sr. VP & Treasurer	Nov 11 '25	Proposed Sale	19.75	18,000	355,500		Nov 12 08:53 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 10 '25	Buy	19.36	8,000	154,907	13,694,579	Nov 12 08:19 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 07 '25	Buy	19.21	8,000	153,650	13,686,579	Nov 12 08:19 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 11 '25	Buy	19.66	7,297	143,460	13,701,876	Nov 12 08:19 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 06 '25	Buy	19.13	8,000	153,034	13,678,579	Nov 07 08:51 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 05 '25	Buy	19.11	8,000	152,847	13,670,579	Nov 07 08:51 AM
MAHAN JON MARSHALL	Director	Nov 05 '25	Option Exercise	14.43	4,500	64,935	13,988	Nov 05 05:52 PM
MAHAN JON MARSHALL	Director	Nov 05 '25	Sale	19.07	4,500	85,810	9,488	Nov 05 05:52 PM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Nov 04 '25	Buy	18.71	8,000	149,704	13,662,579	Nov 05 05:04 PM
MAHAN JON MARSHALL	Director	Nov 05 '25	Proposed Sale	19.09	4,500	85,900		Nov 05 01:10 PM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 12 '25	Buy	19.53	20,000	390,654	13,654,579	Sep 15 08:29 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 10 '25	Buy	18.99	20,000	379,896	13,618,006	Sep 12 09:08 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 11 '25	Buy	19.45	16,573	322,424	13,634,579	Sep 12 09:08 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 09 '25	Buy	19.24	19,352	372,292	13,598,006	Sep 10 08:53 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 08 '25	Buy	19.10	19,025	363,417	13,578,654	Sep 10 08:53 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 04 '25	Buy	19.22	19,212	369,339	13,559,629	Sep 08 08:59 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 03 '25	Buy	18.37	20,000	367,356	13,540,417	Sep 04 08:14 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Sep 02 '25	Buy	18.27	19,440	355,136	13,520,417	Sep 04 08:14 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 29 '25	Buy	17.84	20,000	356,724	13,500,977	Sep 02 10:27 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 28 '25	Buy	17.61	8,032	141,417	13,480,977	Sep 02 10:27 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 26 '25	Buy	17.45	15,815	275,951	13,457,436	Aug 28 09:22 AM
DONEGAL MUTUAL INSURANCE CO	10% Owner	Aug 27 '25	Buy	17.49	15,509	271,325	13,472,945	Aug 28 09:22 AM
KING DAVID CHARLES	Director	Aug 27 '25	Option Exercise	14.43	4,500	64,935	7,000	Aug 28 09:17 AM
KING DAVID CHARLES	Director	Aug 27 '25	Sale	17.51	4,500	78,782	2,500	Aug 28 09:17 AM
KING DAVID CHARLES	Director	Aug 27 '25	Proposed Sale	17.50	4,500	78,750		Aug 27 05:06 PM
HESS JACK LEE	Director	Jul 29 '25	Option Exercise	14.57	4,500	65,580	120,920	Jul 30 10:42 AM
VIOZZI VINCENT ANTHONY	Sr. VP & Chief Inv Officer	May 27 '25	Option Exercise	14.39	18,000	259,020	27,316	May 28 08:58 AM
VIOZZI VINCENT ANTHONY	Sr. VP & Chief Inv Officer	May 27 '25	Sale	20.24	19,173	388,120	8,143	May 28 08:58 AM
VIOZZI VINCENT ANTHONY	Officer	May 27 '25	Proposed Sale	20.36	18,000	366,480		May 27 12:40 PM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Option Exercise	14.39	8,696	125,135	10,191	May 27 10:13 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Sale	19.78	8,696	171,998	1,495	May 27 10:13 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Option Exercise	14.39	8,696	125,135	10,191	May 27 10:10 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 23 '25	Sale	19.78	8,696	171,998	1,495	May 27 10:10 AM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 21 '25	Option Exercise	14.39	304	4,375	1,799	May 22 04:57 PM
DELAMATER WILLIAM DANIEL	EVP & Chief Oper Officer	May 21 '25	Sale	20.50	304	6,232	1,495	May 22 04:57 PM
ALTSHULER KRISTI SPENCER	Officer	May 21 '25	Proposed Sale	20.61	12,000	247,320		May 21 10:03 AM
DELAMATER WILLIAM DANIEL	Officer	May 21 '25	Proposed Sale	20.61	9,000	185,490		May 21 10:01 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 19 '25	Option Exercise	14.02	18,000	252,300	18,950	May 20 08:23 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 19 '25	Sale	20.67	18,000	371,988	950	May 20 08:23 AM
FOLMAR WILLIAM ALBERT	Officer	May 19 '25	Proposed Sale	20.60	18,000	370,800		May 19 10:57 AM
PANDEY SANJAY	Sr. VP & Chief Info Officer	May 15 '25	Option Exercise	14.39	12,982	186,811	20,431	May 19 09:11 AM
PANDEY SANJAY	Sr. VP & Chief Info Officer	May 15 '25	Sale	20.27	12,982	263,171	7,449	May 19 09:11 AM
Huber Barry C	Director	May 15 '25	Option Exercise	14.41	9,000	129,690	24,367	May 15 03:30 PM
Huber Barry C	Director	May 15 '25	Sale	20.23	9,000	182,034	15,367	May 15 03:30 PM
SPONIC DAVID WAYNE	Senior Vice President	May 15 '25	Option Exercise	14.39	11,582	166,665	13,588	May 15 03:27 PM
SPONIC DAVID WAYNE	Senior Vice President	May 15 '25	Sale	20.04	11,582	232,103	2,006	May 15 03:27 PM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 15 '25	Option Exercise	14.39	1,150	16,548	2,100	May 15 03:25 PM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 15 '25	Sale	19.89	1,150	22,868	950	May 15 03:25 PM
HAY JEFFERY TIM	Senior Vice President	May 15 '25	Option Exercise	14.07	9,572	134,678	15,684	May 15 03:22 PM
HAY JEFFERY TIM	Senior Vice President	May 15 '25	Sale	20.01	9,572	191,574	6,112	May 15 03:22 PM
Huber Barry C	Director	May 15 '25	Proposed Sale	20.10	9,000	180,900		May 15 03:01 PM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 13 '25	Option Exercise	14.39	12,576	180,969	13,526	May 15 11:22 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 14 '25	Option Exercise	14.39	4,274	61,503	5,224	May 15 11:22 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 13 '25	Sale	19.90	12,576	250,288	950	May 15 11:22 AM
FOLMAR WILLIAM ALBERT	Sr. Vice President	May 14 '25	Sale	19.82	4,274	84,694	950	May 15 11:22 AM
HAY JEFFERY TIM	Senior Vice President	May 13 '25	Option Exercise	14.07	346	4,868	6,458	May 15 11:14 AM
HAY JEFFERY TIM	Senior Vice President	May 13 '25	Sale	20.01	346	6,923	6,112	May 15 11:14 AM
SPONIC DAVID WAYNE	Senior Vice President	May 13 '25	Option Exercise	14.39	418	6,015	2,424	May 15 11:11 AM
SPONIC DAVID WAYNE	Senior Vice President	May 13 '25	Sale	20.01	418	8,363	2,006	May 15 11:11 AM
FOLMAR WILLIAM ALBERT	Officer	May 13 '25	Proposed Sale	19.81	18,000	356,580		May 13 12:23 PM
DONEGAL MUTUAL INSURANCE CO	10% Owner	May 12 '25	Buy	19.83	71,000	1,408,214	13,441,621	May 13 10:05 AM
MILLER JEFFREY DEAN	EVP & Chief Financial Officer	May 12 '25	Option Exercise	14.43	24,000	346,320	47,980	May 13 10:02 AM
MILLER JEFFREY DEAN	EVP & Chief Financial Officer	May 12 '25	Sale	19.83	24,000	476,016	23,980	May 13 10:02 AM
HOFFMAN CHRISTINA MARIE	Sr. VP & Chief Risk Officer	May 12 '25	Option Exercise	14.43	11,000	158,730	15,405	May 13 09:56 AM
HOFFMAN CHRISTINA MARIE	Sr. VP & Chief Risk Officer	May 12 '25	Sale	19.83	11,000	218,174	4,405	May 13 09:56 AM
BURKE KEVIN GERARD	President & Chief Exec Officer	May 12 '25	Option Exercise	14.43	27,000	389,610	38,672	May 13 09:54 AM
BURKE KEVIN GERARD	President & Chief Exec Officer	May 12 '25	Sale	19.83	27,000	535,518	11,672	May 13 09:54 AM
BAWEL DAVID BENJAMIN	SVP & CHIEF ACCOUNTING OFFICER	May 12 '25	Option Exercise	14.43	9,000	129,870	29,417	May 13 09:47 AM
BAWEL DAVID BENJAMIN	SVP & CHIEF ACCOUNTING OFFICER	May 12 '25	Sale	19.83	9,000	178,506	20,417	May 13 09:47 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 09 '25	Option Exercise	14.21	8,236	117,009	31,623	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 12 '25	Option Exercise	14.20	5,807	82,451	29,194	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 09 '25	Sale	19.87	8,236	163,650	23,387	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 12 '25	Sale	19.86	5,807	115,351	23,387	May 13 09:33 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 08 '25	Option Exercise	14.20	14,606	207,457	37,993	May 09 08:45 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 07 '25	Option Exercise	14.17	200	2,835	23,587	May 09 08:45 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 08 '25	Sale	19.87	14,606	290,207	23,387	May 09 08:45 AM
WAGNER DANIEL J	Sr. VP & Treasurer	May 07 '25	Sale	20.00	200	4,000	23,387	May 09 08:45 AM
HAY JEFFERY TIM	Senior Vice President	May 07 '25	Option Exercise	14.07	82	1,154	6,194	May 09 08:37 AM
HAY JEFFERY TIM	Senior Vice President	May 07 '25	Sale	20.00	82	1,640	6,112	May 09 08:37 AM
SPONIC DAVID WAYNE	Officer	May 08 '25	Proposed Sale	19.74	12,000	236,880		May 08 01:04 PM
WAGNER DANIEL J	Sr. VP & Treasurer	May 05 '25	Option Exercise	14.20	7,151	101,568	30,538	May 06 04:35 PM
WAGNER DANIEL J	Sr. VP & Treasurer	May 05 '25	Sale	20.00	7,151	143,034	23,387	May 06 04:35 PM

Open in Screener

SHBI

Shore Bancshares Inc

Nov 20 • 01:33PM ET

16.11

+0.20 1.29 %

Financial • Banks - Regional • USA • NASD

SHBI Shore Bancshares Inc daily Stock Chart

Peers: SASR EGBN HIFS FFBC VLY TMP NFBK CATY WSBC LSBK

| Held by: VTI IWM AVUV VXF IWN DFAT BSVO VTWO KRE DFSV

Index	RUT	P/E	9.46	EPS (ttm)	1.70	Insider Own	9.76%	Shs Outstand	33.42M	Perf Week	-0.09%
Market Cap	538.67M	Forward P/E	8.38	EPS next Y	1.92	Insider Trans	0.59%	Shs Float	30.16M	Perf Month	1.22%
Enterprise Value	-	PEG	0.52	EPS next Q	0.47	Inst Own	62.45%	Short Float	1.62%	Perf Quarter	-4.02%
Income	56.90M	P/S	1.59	EPS this Y	34.19%	Inst Trans	3.15%	Short Ratio	3.44	Perf Half Y	11.45%
Sales	339.15M	P/B	0.93	EPS next Y	8.59%	ROA	0.93%	Short Interest	0.49M	Perf YTD	1.67%
Book/sh	17.27	P/C	-	EPS next 5Y	18.31%	ROE	10.25%	52W High	17.67 -8.80%	Perf Year	0.34%
Cash/sh	-	P/FCF	6.96	EPS past 3/5Y	4.02% 0.72%	ROIC	7.99%	52W Low	11.47 40.50%	Perf 3Y	-18.78%
Dividend Est.	0.48 (2.98%)	EV/EBITDA	-	Sales past 3/5Y	57.44% 36.32%	Gross Margin	-	Volatility	2.39% 2.78%	Perf 5Y	27.49%
Dividend TTM	0.48 (2.98%)	EV/Sales	-	EPS Y/Y TTM	38.05%	Oper. Margin	22.44%	ATR (14)	0.42	Perf 10Y	60.83%
Dividend Ex-Date	Nov 13, 2025	Quick Ratio	-	Sales Y/Y TTM	6.01%	Profit Margin	16.78%	RSI (14)	52.43	Recom	1.50
Dividend Gr. 3/5Y	0.00% 2.71%	Current Ratio	0.12	EPS Q/Q	27.86%	SMA20	1.32%	Beta	0.92	Target Price	18.38
Payout	36.40%	Debt/Eq	0.24	Sales Q/Q	3.55%	SMA50	-0.55%	Rel Volume	1.58	Prev Close	15.91
Employees	597	LT Debt/Eq	0.23	Earnings	Oct 23 AMC	SMA200	5.28%	Avg Volume	141.79K	Price	16.11
IPO	Apr 09, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.14% -1.35%	Trades		Volume	143,607	Change	1.29%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-19-25	Initiated	Hovde Group	Outperform	$19
Feb-06-25	Initiated	Piper Sandler	Overweight	$20
Dec-04-24	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$16 → $20
Jul-30-24	Downgrade	Janney	Buy → Neutral
Aug-15-23	Upgrade	Janney	Neutral → Buy
Dec-13-22	Downgrade	Keefe Bruyette	Outperform → Mkt Perform	$22
Dec-05-22	Resumed	Piper Sandler	Overweight	$22
Aug-31-22	Initiated	Janney	Neutral
Nov-04-21	Upgrade	Piper Sandler	Neutral → Overweight	$15 → $22
Mar-08-21	Upgrade	Keefe Bruyette	Mkt Perform → Outperform	$15 → $20
Feb-04-19	Downgrade	Keefe Bruyette	Outperform → Mkt Perform
Mar-12-15	Upgrade	Boenning & Scattergood	Neutral → Outperform	$10.50
Sep-01-10	Upgrade	BB&T Capital Mkts	Hold → Buy
Jul-14-08	Initiated	Boenning & Scattergood	Market Outperform	$20.50
Sep-24-07	Initiated	Ferris Baker Watts	Neutral
Jun-25-07	Downgrade	BB&T Capital Mkts	Buy → Hold
Mar-19-07	Upgrade	BB&T Capital Mkts	Hold → Buy	$27

Show Previous Ratings

Nov-13-25 04:00PM	Shore Bancshares, Inc. Announces Completion of $60 Million Subordinated Notes Offering (PR Newswire)
Nov-10-25 09:40AM	Should Value Investors Buy Shore Bancshares (SHBI) Stock? (Zacks)
Nov-03-25 04:01PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Oct-31-25 09:40AM	Are Investors Undervaluing LCNB (LCNB) Right Now? (Zacks)
Oct-23-25 07:00PM	Compared to Estimates, Shore Bancshares (SHBI) Q3 Earnings: A Look at Key Metrics (Zacks)
05:15PM	Loading…
05:15PM	Shore Bancshares (SHBI) Q3 Earnings Top Estimates (Zacks)
04:10PM	Shore Bancshares: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Shore Bancshares, Inc. Reports 2025 Third Quarter Results (PR Newswire)
Aug-01-25 04:00PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Jul-30-25 09:40AM	Are Investors Undervaluing Shore Bancshares (SHBI) Right Now? (Zacks)
Jul-25-25 07:54AM	Shore Bancshares: Q2 Earnings Snapshot (Associated Press Finance)
Jul-24-25 06:30PM	Shore Bancshares (SHBI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:15PM	Shore Bancshares (SHBI) Q2 Earnings and Revenues Surpass Estimates (Zacks)
04:00PM	Shore Bancshares, Inc. Reports 2025 Second Quarter Results (PR Newswire)
Jul-21-25 09:11AM	Beat the Market the Zacks Way: Curtiss-Wright, Oracle, Starbucks in Focus (Zacks)
10:00AM	Loading…
Jul-17-25 10:00AM	Shore Bancshares (SHBI) to Report Q2 Results: Wall Street Expects Earnings Growth (Zacks)
Jul-10-25 09:55AM	Shore Bancshares (SHBI) Just Flashed Golden Cross Signal: Do You Buy? (Zacks)
Jul-03-25 12:00PM	Are You Looking for a Top Momentum Pick? Why Shore Bancshares (SHBI) is a Great Choice (Zacks)
Jun-30-25 10:00AM	Best Momentum Stocks to Buy for June 30th (Zacks)
06:21AM	New Strong Buy Stocks for June 30th (Zacks)
05:29AM	Best Value Stocks to Buy for June 30th (Zacks)
Jun-12-25 09:40AM	Is Shore Bancshares (SHBI) Stock Undervalued Right Now? (Zacks)
May-27-25 09:40AM	Should Value Investors Buy Shore Bancshares (SHBI) Stock? (Zacks)
06:19AM	New Strong Buy Stocks for May 27th (Zacks)
May-01-25 04:00PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Apr-29-25 10:30AM	Shore Bancshares (SHBI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) +7.15%
09:40AM	Shore Bancshares (SHBI) Tops Q1 Earnings and Revenue Estimates (Zacks)
08:38AM	Shore Bancshares: Q1 Earnings Snapshot (Associated Press Finance)
08:30AM	Shore Bancshares, Inc. Reports 2025 First Quarter Results (PR Newswire)
Apr-28-25 05:25PM	Financial Institutions (FISI) Surpasses Q1 Earnings Estimates (Zacks)
07:10AM	Loading…
Apr-25-25 07:10AM	Flagstar Financial (FLG) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
Apr-24-25 08:45AM	Webster Financial (WBS) Q1 Earnings and Revenues Lag Estimates (Zacks)
Apr-23-25 09:10AM	Hanover Bancorp, Inc. (HNVR) Q1 Earnings and Revenues Top Estimates (Zacks)
Apr-17-25 11:58AM	Shore Bancshares, Inc. Announces Appointment of Charles Cullum as Executive Vice President and Chief Financial Officer Following the Previously Announced Retirement of Chief Financial Officer (PR Newswire)
Feb-13-25 12:00PM	Shore Bancshares (SHBI) is a Great Momentum Stock: Should You Buy? (Zacks)
Jan-30-25 06:25PM	Shore Bancshares (SHBI) Q4 Earnings and Revenues Beat Estimates (Zacks)
05:32PM	Shore Bancshares: Q4 Earnings Snapshot (Associated Press Finance)
05:07PM	Shore Bancshares, Inc. Reports 2024 Fourth Quarter and Annual Results (PR Newswire)
Oct-30-24 04:15PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Oct-24-24 04:34PM	Shore Bancshares: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Shore Bancshares, Inc. Reports Three and Nine Months Financial Results (PR Newswire)
Aug-01-24 04:30PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Jul-25-24 06:46AM	Shore Bancshares: Q2 Earnings Snapshot (Associated Press Finance)
06:30AM	Shore Bancshares, Inc. Reports Second Quarter and First-Half Financial Results (PR Newswire)
May-16-24 05:46PM	Shore Bancshares Files $175 Million Mixed Shelf (MT Newswires)
May-02-24 06:00PM	Shore Bancshares (SHBI) Tops Q1 Earnings Estimates (Zacks)
05:12PM	Shore Bancshares: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Shore Bancshares, Inc. Reports 2024 First Quarter Financial Results (PR Newswire)
Feb-02-24 04:15PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Jan-31-24 05:22PM	Shore Bancshares: Q4 Earnings Snapshot (Associated Press Finance) -5.41% -6.18%
04:15PM	Shore Bancshares, Inc. Reports 2023 Fourth Quarter and Annual Results (PR Newswire)
Dec-14-23 07:51AM	Shore Bancshares (SHBI) Soars 7.3%: Is Further Upside Left in the Stock? (Zacks)
Nov-07-23 04:15PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Nov-03-23 06:04AM	Shore Bancshares Inc (SHBI) Reports Q3 2023 Net Loss of $6.4 Million Due to Merger Activity (GuruFocus.com) +8.84%
Nov-01-23 07:50AM	Shore Bancshares: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Shore Bancshares, Inc. Reports Third Quarter 2023 Net Loss of $6.4 million Due to One-Time Merger Related Activity (PR Newswire)
Oct-19-23 10:01AM	Shore Bancshares (SHBI) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Aug-26-23 12:57PM	Ken Fishers 12 New Stock Picks (Insider Monkey)
Aug-03-23 07:04PM	10 Oversold Bank Stocks To Buy (Insider Monkey)
Jul-29-23 08:12AM	Shore Bancshares (NASDAQ:SHBI) Is Paying Out A Dividend Of $0.12 (Simply Wall St.)
Jul-27-23 08:30PM	Shore Bancshares (SHBI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks) -7.98%
06:25PM	Shore Bancshares (SHBI) Misses Q2 Earnings and Revenue Estimates (Zacks)
05:13PM	Shore Bancshares: Q2 Earnings Snapshot (Associated Press Finance)
Jul-25-23 04:30PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
Jul-20-23 10:02AM	Analysts Estimate Shore Bancshares (SHBI) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-19-23 11:57AM	Several Insiders Invested In Shore Bancshares Flagging Positive News (Simply Wall St.)
Jul-11-23 12:03PM	NBT Bancorp (NBTB) & Salisbury Get Regulatory Nod for Merger (Zacks)
Jul-05-23 01:17PM	Shore Bancshares (SHBI) Wraps Up Community Financial Merger (Zacks)
Jul-03-23 09:00AM	Shore Bancshares, Inc. and The Community Financial Corporation Complete Merger (PR Newswire)
Jun-21-23 11:47AM	Shore Bancshares (SHBI) Gets Shareholder Nod for TCFC Merger (Zacks)
Jun-20-23 05:00PM	Shore Bancshares, Inc. and The Community Financial Corporation Announce Receipt of Shareholder Approval for Merger of Equals (PR Newswire)
Jun-06-23 09:06AM	Institutional investors own a significant stake of 46% in Shore Bancshares, Inc. (NASDAQ:SHBI) (Simply Wall St.)
May-07-23 08:10AM	Shore Bancshares (NASDAQ:SHBI) Will Pay A Dividend Of $0.12 (Simply Wall St.)
May-03-23 04:15PM	Shore Bancshares, Inc. Reports Quarterly Dividend of $0.12 Per Share (PR Newswire)
May-01-23 06:45AM	Daily Vickers Top Insider Picks for 05/01/2023 (Argus Research)
Apr-28-23 07:04AM	Daily Vickers Top Insider Picks for 04/28/2023 (Argus Research)
Apr-27-23 06:35PM	Shore Bancshares (SHBI) Misses Q1 Earnings and Revenue Estimates (Zacks)
05:24PM	Shore Bancshares: Q1 Earnings Snapshot (AP Finance)
06:47AM	Daily Vickers Top Insider Picks for 04/27/2023 (Argus Research)
Apr-26-23 06:26AM	Daily Vickers Top Insider Picks for 04/26/2023 (Argus Research)
Apr-25-23 05:25PM	The Community Financial Corporation Reports EPS of $1.30 and ROAA of 1.21% For the First Quarter 2023 (GlobeNewswire)
Apr-20-23 07:03AM	Daily Vickers Top Insider Picks for 04/20/2023 (Argus Research)
Apr-19-23 06:53AM	Daily Vickers Top Insider Picks for 04/19/2023 (Argus Research)
Apr-17-23 06:54AM	Daily Vickers Top Insider Picks for 04/17/2023 (Argus Research)
Apr-14-23 06:37AM	Daily Vickers Top Insider Picks for 04/14/2023 (Argus Research)
Apr-13-23 09:35AM	Down -7.32% in 4 Weeks, Here's Why You Should You Buy the Dip in Shore Bancshares (SHBI) (Zacks)
06:52AM	Daily Vickers Top Insider Picks for 04/13/2023 (Argus Research)
Apr-12-23 07:07AM	Daily Vickers Top Insider Picks for 04/12/2023 (Argus Research)
Apr-11-23 06:58AM	Daily Vickers Top Insider Picks for 04/11/2023 (Argus Research)
Apr-10-23 06:44AM	Daily Vickers Top Insider Picks for 04/10/2023 (Argus Research)
Apr-07-23 07:44AM	Daily Vickers Top Insider Picks for 04/07/2023 (Argus Research)
Apr-06-23 07:20AM	Daily Vickers Top Insider Picks for 04/06/2023 (Argus Research)
Apr-05-23 06:11AM	Daily Vickers Top Insider Picks for 04/05/2023 (Argus Research)
Apr-04-23 07:08AM	Daily Vickers Top Insider Picks for 04/04/2023 (Argus Research)
Apr-03-23 06:48AM	Daily Vickers Top Insider Picks for 04/03/2023 (Argus Research)
Mar-31-23 06:36AM	Daily Vickers Top Insider Picks for 03/31/2023 (Argus Research)
Mar-30-23 06:36AM	Daily Vickers Top Insider Picks for 03/30/2023 (Argus Research)
Mar-29-23 06:32AM	Daily Vickers Top Insider Picks for 03/29/2023 (Argus Research)
Mar-28-23 06:46AM	Daily Vickers Top Insider Picks for 03/28/2023 (Argus Research)
Mar-24-23 06:42AM	Daily Vickers Top Insider Picks for 03/24/2023 (Argus Research)

Shore Bancshares, Inc. is a financial holding company, which engages in the provision of commercial banking products and services to individuals and businesses. Its services include checking accounts, various savings programs, mortgage loans, home improvement loans, installment and other personal loans, credit cards, personal lines of credit, automobile and other consumer financing, safe deposit boxes, debit cards, 24-hour telephone banking, internet banking, mobile banking, and 24-hour automatic teller machine services. It also offers commercial checking, savings, certificates of deposit, and overnight investment sweep accounts. The company was founded on March 15, 1996 and is headquartered in Easton, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kaslow Aaron Michael	EVP, Chief Legal Officer	Nov 18 '25	Buy	15.56	6,500	101,140	6,500	Nov 20 11:33 AM
LAMON JOHN	Director	Nov 07 '25	Buy	15.92	200	3,184	62,378	Nov 10 11:33 AM
WAYSON KONRAD	Director	Aug 13 '25	Buy	16.02	1,000	16,020	60,731	Aug 13 02:22 PM
Adams Michael Brian	Director	Aug 01 '25	Buy	15.00	10,000	150,000	44,912	Aug 04 12:26 PM
LAMON JOHN	Director	May 30 '25	Buy	14.55	250	3,638	62,132	Jun 02 12:27 PM
Willey Dawn M.	Director	May 30 '25	Buy	14.58	1,000	14,578	17,591	Jun 02 12:26 PM
Streete Esther A.	Director	May 30 '25	Buy	14.58	30	437	657	Jun 02 12:24 PM
Adams Michael Brian	Director	May 02 '25	Buy	14.15	560	7,922	9,758	May 06 02:09 PM
WAYSON KONRAD	Director	May 02 '25	Buy	14.25	5,000	71,248	59,328	May 02 02:04 PM
STEVENS DONNA J.	EVP, Chief Operating Officer	Feb 20 '25	Buy	15.85	315	4,993	1,815	Feb 24 02:37 PM
Adams Michael Brian	Director	Feb 04 '25	Buy	15.92	965	15,363	9,126	Feb 06 10:29 AM
WAYSON KONRAD	Director	Nov 25 '24	Buy	16.94	3,000	50,820	53,266	Nov 25 05:22 PM

Open in Screener

FOSL

Fossil Group Inc

Nov 20 • 01:33PM ET

2.28

+0.25 12.07 %

Consumer Cyclical • Footwear & Accessories • USA • NASD

Peers: LEVI MOV PVH RL GES VFC LB SIG UAA

| Held by: VTI VXF AVUV IWC BSVO PRFZ AVSC DFAC DFAS DCOR

Index	-	P/E	-	EPS (ttm)	-1.28	Insider Own	8.60%	Shs Outstand	51.35M	Perf Week	8.33%
Market Cap	124.31M	Forward P/E	-	EPS next Y	-	Insider Trans	5.77%	Shs Float	49.94M	Perf Month	-2.36%
Enterprise Value	363.92M	PEG	-	EPS next Q	-0.02	Inst Own	51.95%	Short Float	9.72%	Perf Quarter	-22.09%
Income	-67.34M	P/S	0.12	EPS this Y	-	Inst Trans	0.20%	Short Ratio	5.33	Perf Half Y	46.77%
Sales	1.07B	P/B	1.04	EPS next Y	-	ROA	-8.90%	Short Interest	4.86M	Perf YTD	36.23%
Book/sh	2.19	P/C	1.49	EPS next 5Y	-	ROE	-48.62%	52W High	4.40 -48.30%	Perf Year	75.00%
Cash/sh	1.53	P/FCF	-	EPS past 3/5Y	- -13.21%	ROIC	-17.25%	52W Low	0.86 165.46%	Perf 3Y	-53.85%
Dividend Est.	-	EV/EBITDA	8.31	Sales past 3/5Y	-15.09% -12.38%	Gross Margin	55.72%	Volatility	13.13% 8.68%	Perf 5Y	-70.72%
Dividend TTM	-	EV/Sales	0.34	EPS Y/Y TTM	45.32%	Oper. Margin	2.84%	ATR (14)	0.26	Perf 10Y	-95.54%
Dividend Ex-Date	-	Quick Ratio	1.00	Sales Y/Y TTM	-12.89%	Profit Margin	-6.32%	RSI (14)	52.45	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.56	EPS Q/Q	-26.39%	SMA20	10.28%	Beta	1.62	Target Price	5.00
Payout	-	Debt/Eq	3.02	Sales Q/Q	-6.12%	SMA50	-7.76%	Rel Volume	4.95	Prev Close	2.03
Employees	5200	LT Debt/Eq	2.47	Earnings	Nov 13 AMC	SMA200	23.64%	Avg Volume	911.70K	Price	2.28
IPO	Apr 08, 1993	Option/Short	Yes / Yes	EPS/Sales Surpr.	-75.00% 15.82%	Trades		Volume	2,899,671	Change	12.07%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-01-25	Initiated	Maxim Group	Buy	$5
Feb-27-20	Reiterated	Telsey Advisory Group	Market Perform	$7 → $5
Nov-07-19	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Aug-05-19	Reiterated	Telsey Advisory Group	Market Perform	$15 → $12
Feb-14-19	Reiterated	Telsey Advisory Group	Market Perform	$17 → $15
Feb-08-19	Reiterated	Telsey Advisory Group	Market Perform	$20 → $17
Aug-03-18	Reiterated	Telsey Advisory Group	Market Perform	$16 → $27
Feb-14-18	Reiterated	Telsey Advisory Group	Market Perform	$7 → $15
Jan-05-18	Downgrade	Buckingham Research	Neutral → Underperform
Aug-09-17	Reiterated	Telsey Advisory Group	Market Perform	$13 → $11
Jun-20-17	Upgrade	Buckingham Research	Underperform → Neutral
May-10-17	Reiterated	Telsey Advisory Group	Market Perform	$23 → $16
Mar-03-17	Reiterated	Macquarie	Underperform	$16 → $12
Feb-15-17	Reiterated	Telsey Advisory Group	Market Perform	$27 → $23
Feb-15-17	Reiterated	Mizuho	Underperform	$19 → $17
Feb-15-17	Downgrade	Wells Fargo	Market Perform → Underperform
Feb-10-17	Downgrade	Mizuho	Neutral → Underperform	$25 → $19
Nov-21-16	Upgrade	Piper Jaffray	Underweight → Neutral
Nov-16-16	Upgrade	KeyBanc Capital Mkts	Sector Weight → Overweight
Nov-04-16	Reiterated	Telsey Advisory Group	Market Perform	$32 → $27

Show Previous Ratings

Nov-19-25 01:16PM	Fossil Stock Sinks 18% as Q3 Loss Widens Y/Y Amid DTC Weakness (Zacks) +6.84%
Nov-14-25 12:06AM	Fossil Group Inc (FOSL) Q3 2025 Earnings Call Highlights: Strategic Debt Restructuring and ... (GuruFocus.com) -9.29%
Nov-13-25 04:17PM	Fossil Group: Q3 Earnings Snapshot (Associated Press Finance) -9.09%
04:01PM	Fossil Group, Inc. Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-10-25 10:51AM	Fossil Announces Grant of Sanction Order (GlobeNewswire) +5.26%
04:05PM	Loading…
Nov-06-25 04:05PM	Announcement Regarding the Result of the Fossil Plan Meeting (GlobeNewswire) -12.20% +5.56%
Nov-04-25 04:05PM	Announcement Regarding Access to the Plan Company's Evidence Ahead of the Sanction Hearing (GlobeNewswire)
Oct-31-25 03:49AM	The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage (Zacks)
Oct-30-25 05:00PM	Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir (Zacks)
04:45PM	Announcement Regarding Fossil Group Plan Meeting to Be Held on Thursday, November 6, 2025 (GlobeNewswire)
04:05PM	Fossil Group, Inc. Announces Date for Third Quarter 2025 Earnings Release and Conference Call (GlobeNewswire)
Oct-23-25 06:00AM	Fossil Announces Intention to Proceed with the UK Proceeding and Extension of Exchange Offer for Its Senior Notes (GlobeNewswire)
Oct-16-25 04:05PM	Fossil Group Announces Notice of Plan Meeting (GlobeNewswire) -29.60% -9.85%
06:00AM	Fossil Announces Further Extension of Exchange Offer for Its Senior Notes (GlobeNewswire)
Oct-14-25 01:21PM	Fossil Climbs 62% Year to Date: Should You Buy the Stock? (Zacks)
09:32PM	Loading…
Oct-08-25 09:32PM	Fossil Announces Convening Hearing for Restructuring Plan (GlobeNewswire)
08:30AM	Fossil Announces Extension of Exchange Offer For Its Senior Notes (GlobeNewswire)
Sep-09-25 06:00PM	Fossil Group, Inc. Announces Commencement of Exchange Offer, Consent Solicitation and Rights Offering Relating to Its Senior Notes (GlobeNewswire)
Aug-21-25 06:07AM	The Zacks Analyst Blog Highlights Amazon.com, Salesforce, Abbott Laboratories and Fossil Group (Zacks)
Aug-20-25 08:40PM	Top Research Reports for Amazon.com, Salesforce & Abbott (Zacks) -6.33%
12:22AM	Fossil Group (FOSL) Net Loss Narrows Despite Sales Decline (Insider Monkey)
Aug-19-25 11:55AM	FOSL Incurs Narrower Y/Y Loss in Q2, Lifts 2025 Outlook (Zacks)
Aug-14-25 03:13AM	Fossil Group Inc (FOSL) Q2 2025 Earnings Call Highlights: Strong Margin Expansion and Strategic ... (GuruFocus.com) +29.83%
Aug-13-25 04:21PM	Fossil Group: Q2 Earnings Snapshot (Associated Press Finance)
04:06PM	Fossil Group, Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
04:05PM	Fossil Group, Inc. Announces ABL Refinancing and Transaction Support Agreement for Debt Exchange (GlobeNewswire)
Jul-30-25 04:55PM	Fossil Group, Inc. Announces Date for Second Quarter 2025 Earnings Release and Conference Call (GlobeNewswire)
Jul-22-25 01:33PM	FOSL Upgraded to Outperform Amid Turnaround Plan, Margin Gains (Zacks) +11.95%
Jul-18-25 09:43AM	The Zacks Analyst Blog Highlights Alphabet, Oracle, Shell, Fossil and ImmuCell (Zacks)
Jul-17-25 11:46PM	Top Research Reports for Alphabet, Oracle & Shell (Zacks)
08:00AM	Loading…
Jul-02-25 08:00AM	Fossil Group Appoints Laks Lakshmanan as Chief Supply Chain Officer (GlobeNewswire) +5.70%
May-20-25 01:38PM	Fossil's Q1 Loss Narrows Y/Y as Watch Sales Drive Turnaround Plan (Zacks)
May-15-25 07:57AM	Q1 2025 Fossil Group Inc Earnings Call (Thomson Reuters StreetEvents) +15.87%
03:18AM	Fossil Group Inc (FOSL) Q1 2025 Earnings Call Highlights: Turnaround Efforts Yield Improved ... (GuruFocus.com)
May-14-25 04:23PM	Fossil Group: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	FOSSIL GROUP APPOINTS PAMELA EDWARDS AND WENDY SCHOPPERT TO BOARD OF DIRECTORS (PR Newswire)
04:06PM	Fossil Group, Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
Apr-30-25 04:05PM	Fossil Group, Inc. Announces Date for First Quarter 2025 Earnings Release and Conference Call (GlobeNewswire)
Apr-15-25 06:24PM	Fossil Group, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Mar-13-25 01:16PM	Fossil Group Stock Surges on Turnaround Plan With Layoffs, Store Closures (Investopedia) +29.13%
10:25AM	Casper Sleep CFO joins Fossil Group (Chain Store Age)
08:34AM	Fossil leans on layoffs, more store closures to cut costs (Retail Dive)
06:50AM	Q4 2024 Fossil Group Inc Earnings Call (Thomson Reuters StreetEvents)
03:08AM	Fossil Group Inc (FOSL) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Mar-12-25 05:30PM	Fossil to Close Stores, Cut Jobs in Effort to Trim Costs (The Wall Street Journal)
04:32PM	Fossil Group: Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	FOSSIL GROUP, INC. APPOINTS RANDY GREBEN AS CHIEF FINANCIAL OFFICER (PR Newswire)
04:05PM	Fossil Group, Inc. Reports Fourth Quarter and Full Year 2024 Results (GlobeNewswire)
Feb-26-25 04:05PM	Fossil Group, Inc. Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call (GlobeNewswire)
Feb-13-25 09:00AM	FOSSIL GROUP, INC. ANNOUNCES CONTINUED PARTNERSHIP WITH MICHAEL KORS TO CREATE WATCHES AND JEWELRY (PR Newswire) +6.79%
Feb-07-25 12:38PM	Fossil Group names new commercial, digital information leaders (Chain Store Age)
Feb-06-25 03:47PM	Fossil Group Poaches Adidas and Salomon Executives for C-Suite Roles (Footwear News)
08:00AM	FOSSIL GROUP, INC. APPOINTS TWO CONSUMER INDUSTRY VETERANS (PR Newswire)
Jan-10-25 09:30AM	Amazon says Buy with Prime to expand with launch of new brand Fossil (TipRanks) -5.74%
Nov-12-24 05:00AM	EXCLUSIVE: Nick Jonas Named Fossil Brand Ambassador (WWD)
Nov-08-24 12:02PM	Fossil Group Inc (FOSL) Q3 2024 Earnings Call Highlights: Strategic Shifts Amidst Sales Decline (GuruFocus.com) -8.66%
Nov-07-24 05:29PM	Fossil Group: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Fossil Group, Inc. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Oct-24-24 04:05PM	Fossil Group, Inc. Announces Date for Third Quarter 2024 Earnings Release and Conference Call (GlobeNewswire)
Oct-15-24 07:00AM	Fossil Group, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) (GlobeNewswire)
Sep-25-24 01:02PM	Fossil Group Inc (FOSL) Q2 2024 Earnings Call Transcript Highlights: Key Takeaways and ... (GuruFocus.com) -5.45%
Sep-05-24 01:58PM	Fossil Group taps outdoor apparel veteran as new CEO (Chain Store Age)
Sep-04-24 08:30AM	Fossil Group, Inc. Appoints Brand Veteran Franco Fogliato as CEO (GlobeNewswire) -6.31%
Aug-09-24 01:15PM	Fossil's (FOSL) Q2 Loss Widens Y/Y on Sales Decline, Margin Up (Zacks)
Aug-08-24 04:47PM	Fossil Group: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Fossil Group, Inc. Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-25-24 04:05PM	Fossil Group, Inc. Announces Date for Second Quarter 2024 Earnings Release and Conference Call (GlobeNewswire) +7.98%
Jul-01-24 09:00AM	Fossil Group, Inc. Announces CFO Transition (GlobeNewswire)
May-15-24 06:04AM	Why the 2024 meme stock action is much tamer than 2021 so far (Yahoo Finance) -7.38%
May-10-24 09:51AM	Fossil Group, Inc. (NASDAQ:FOSL) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-09-24 06:56AM	Q1 2024 Fossil Group Inc Earnings Call (Thomson Reuters StreetEvents)
03:53AM	Fossil Group Inc (FOSL) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-08-24 10:55PM	FOSL Stock Earnings: Fossil Group Reported Results for Q1 2024 (InvestorPlace)
06:30PM	Fossil Group Sees First-Quarter Revenues Slide After a Dismal 2023 (WWD)
06:06PM	Fossil Group: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Fossil Group, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-02-24 01:09PM	Fossil Group (FOSL) Fell Due to Near-Term Revenue Headwinds (Insider Monkey) +12.68%
12:56PM	Gray Television (GTN) Was Under Pressure in Q1 (Insider Monkey)
Apr-24-24 04:05PM	Fossil Group, Inc. Announces Date for First Quarter 2024 Earnings Release and Conference Call (GlobeNewswire)
Apr-18-24 03:26PM	Kanen Wealth Management Excoriates Fossil Board of Directors and Management for Unacceptably Slow Restructuring Plan (GlobeNewswire)
Mar-25-24 04:05PM	Fossil Group Announces Appointment of Eugene Davis and Pamela Corrie to Board of Directors (GlobeNewswire)
Mar-16-24 02:12PM	Fossil Group, Inc. (NASDAQ:FOSL) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 08:36PM	Longtime CEO of Fossil out amid strategic review; Kevin Mansell named chairman (Chain Store Age) -6.51% +7.41%
06:34AM	Q4 2023 Fossil Group Inc Earnings Call (Thomson Reuters StreetEvents)
01:36AM	PRESS DIGEST-Wall Street Journal - March 14 (Reuters)
Mar-13-24 04:40PM	Fossil Group: Q4 Earnings Snapshot (Associated Press Finance)
04:06PM	Fossil Group, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results (GlobeNewswire)
04:05PM	Fossil Group, Inc. Announces Leadership Changes (GlobeNewswire)
Mar-07-24 05:13PM	15 Best Apple Watch Alternatives in 2024 (Insider Monkey)
Mar-06-24 07:00AM	Fossil Group, Inc. Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call (GlobeNewswire)
Feb-20-24 02:00PM	Fossil Group, Inc. Confirms Receipt of Director Nominations From Buxton Helmsley Group, Inc. (GlobeNewswire)
08:30AM	BUXTON HELMSLEY NOMINATES FOUR HIGHLY QUALIFIED DIRECTORS TO FOSSIL GROUP BOARD TO HELP END YEARS OF SHAREHOLDER SUFFERING (PR Newswire)
07:35AM	Investor names director candidates at Fossil Group after stock price drop (Reuters)
Jan-04-24 10:06AM	Fossil Taps Tangiblee for First of Its Kind Virtual Try-on Experience (WWD)
Dec-21-23 02:08PM	CSA Exclusive: Fossil offers multi-category virtual try-on (Chain Store Age)
Nov-30-23 05:52PM	Fossil mobile-enables in-store checkout (Chain Store Age)
Nov-28-23 08:00AM	Fossil Group Selects NewStore Omnichannel Platform to Transform its Shopping Experience Globally (PR Newswire)
Nov-10-23 12:36PM	Fossil Group, Inc. (NASDAQ:FOSL) Q3 2023 Earnings Call Transcript (Insider Monkey) +13.68%
Nov-09-23 10:49AM	Q3 2023 Fossil Group Inc Earnings Call (Thomson Reuters StreetEvents) -32.37%
Nov-08-23 06:40PM	Fossil Group: Q3 Earnings Snapshot (Associated Press Finance)

Fossil Group, Inc. engages in the design, marketing and distribution of consumer fashion accessories. The firm operates through the following geographical segments: Americas, Europe, and Asia. Its products include men's and women's fashion watches, jewelry, handbags, small leather goods, belts, sunglasses, shoes, soft accessories and clothing which are sold through department stores, specialty retail locations, specialty watch and jewelry stores, owned retail and factory outlet stores, mass market stores, owned, and affiliate internet sites. The company was founded by Tom Kartsotis in 1984 and is headquartered in Richardson, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Martin Joe T	Chief Commercial Officer	Nov 18 '25	Buy	1.78	56,180	100,000	185,761	Nov 20 09:01 AM
Fogliato Franco	CEO	Nov 18 '25	Buy	1.80	200,000	359,500	1,950,000	Nov 19 05:18 PM
Fogliato Franco	CEO	Nov 27 '24	Buy	1.49	138,825	206,849	1,750,000	Nov 29 01:39 PM
Fogliato Franco	CEO	Nov 26 '24	Buy	1.37	111,175	152,310	1,611,175	Nov 29 01:39 PM

Open in Screener

MPB

Mid Penn Bancorp, Inc

Nov 20 • 01:32PM ET

28.34

+0.10 0.37 %

Financial • Banks - Regional • USA • NASD

MPB Mid Penn Bancorp, Inc daily Stock Chart

Peers: OCFC FUNC FULT STBA UVSP CZNC TRST CIVB MBWM BMRC

| Held by: VTI IWM VXF AVUV IWN KRE SCHA VTWO BSVO DFAT

Index	RUT	P/E	11.64	EPS (ttm)	2.44	Insider Own	18.86%	Shs Outstand	23.04M	Perf Week	-3.13%
Market Cap	653.31M	Forward P/E	7.83	EPS next Y	3.62	Insider Trans	0.32%	Shs Float	18.87M	Perf Month	1.74%
Enterprise Value	-	PEG	0.79	EPS next Q	0.84	Inst Own	49.79%	Short Float	3.69%	Perf Quarter	-5.20%
Income	50.03M	P/S	1.94	EPS this Y	10.97%	Inst Trans	4.52%	Short Ratio	5.66	Perf Half Y	5.41%
Sales	337.10M	P/B	0.82	EPS next Y	17.34%	ROA	0.85%	Short Interest	0.70M	Perf YTD	-1.72%
Book/sh	34.56	P/C	-	EPS next 5Y	14.70%	ROE	7.31%	52W High	33.87 -16.30%	Perf Year	-10.16%
Cash/sh	-	P/FCF	12.26	EPS past 3/5Y	2.24% 6.80%	ROIC	5.87%	52W Low	22.50 25.98%	Perf 3Y	-15.39%
Dividend Est.	0.83 (2.93%)	EV/EBITDA	-	Sales past 3/5Y	28.72% 23.41%	Gross Margin	-	Volatility	2.01% 2.24%	Perf 5Y	26.18%
Dividend TTM	0.82 (2.89%)	EV/Sales	-	EPS Y/Y TTM	-15.97%	Oper. Margin	21.81%	ATR (14)	0.66	Perf 10Y	84.93%
Dividend Ex-Date	Nov 10, 2025	Quick Ratio	-	Sales Y/Y TTM	12.09%	Profit Margin	14.84%	RSI (14)	44.87	Recom	1.00
Dividend Gr. 3/5Y	0.42% 3.00%	Current Ratio	0.07	EPS Q/Q	6.43%	SMA20	-2.15%	Beta	0.54	Target Price	36.00
Payout	27.62%	Debt/Eq	0.10	Sales Q/Q	19.57%	SMA50	-2.11%	Rel Volume	0.41	Prev Close	28.24
Employees	614	LT Debt/Eq	0.07	Earnings	Oct 22 AMC	SMA200	1.04%	Avg Volume	123.01K	Price	28.34
IPO	Jan 17, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.45% 5.84%	Trades		Volume	32,236	Change	0.37%

Date	Action	Analyst	Rating Change	Price Target Change
May-05-21	Upgrade	Piper Sandler	Neutral → Overweight	$27 → $30
May-03-21	Initiated	Stephens	Overweight	$30
Feb-28-20	Initiated	Piper Sandler	Neutral	$24
Apr-17-19	Initiated	DA Davidson	Neutral

Oct-22-25 05:19PM	Mid Penn Bancorp, Inc. Reports Third Quarter Earnings and Declares 60th Consecutive Quarterly Dividend (Business Wire)
Sep-29-25 07:13AM	Mid Penn to buy NJ bank, Florida investment firm (Banking Dive)
Sep-25-25 04:01PM	Mid Penn Bancorp, Inc. to Acquire Cumberland Advisors (Business Wire)
01:43PM	Norcross-backed Mid Penn Bancorp agrees to buy Mount Laurel-based 1st Colonial Bancorp (Courier Post)
Sep-24-25 04:01PM	Mid Penn Bancorp, Inc. Announces Agreement to Acquire 1st Colonial Bancorp, Inc. (Business Wire)
05:31PM	Loading…
Jul-23-25 05:31PM	Mid Penn Bancorp, Inc. Reports Second Quarter Earnings and Declares 59th Consecutive Quarterly Dividend (Business Wire) -7.90%
May-02-25 04:19PM	Paramount Global, Mid Penn Bancorp, and More Stocks See Action From Activist Investors (Barrons.com)
May-01-25 08:30AM	Mid Penn Bancorp, Inc. Completes Acquisition of William Penn Bancorporation (Business Wire)
Apr-23-25 04:32PM	Mid Penn Bancorp, Inc. Reports First Quarter Earnings and Declares 58th Consecutive Quarterly Dividend (Business Wire)
Apr-11-25 03:07PM	Couchbase, Staar Surgical, Zymeworks, and More Stocks See Action From Activist Investors (Barrons.com)
Apr-07-25 02:39PM	Mid Penn Bancorp, Inc. (MPB): Among Small-Cap Stocks Insiders Were Buying in Q1 2025 (Insider Monkey)
Apr-02-25 05:48PM	Mid Penn Bancorp, Inc. and William Penn Bancorporation Receive Shareholder Approvals for Merger (Business Wire) -8.22%
Mar-28-25 03:55PM	Mid Penn Bancorp, Inc. and William Penn Bancorporation Receive Regulatory Approvals for Merger (Business Wire)
Feb-07-25 01:31PM	Is Mid Penn Bancorp (MPB) Among the Small Cap Stocks Insiders Are Buying Recently? (Insider Monkey)
Jan-22-25 06:50PM	Mid Penn Bancorp (MPB) Lags Q4 Earnings Estimates (Zacks)
06:16PM	Loading…
06:16PM	Mid Penn Bancorp, Inc. Reports Fourth Quarter and Full Year Earnings Beat and Declares 57th Consecutive Quarterly Dividend (Business Wire)
Nov-04-24 06:18PM	Mid Penn Bancorp, Inc. Announces Closing of Public Offering of Common Stock (Business Wire)
07:07AM	Mid Penn Bancorp to acquire in-state peer in $127M deal (Banking Dive)
04:42AM	Mid Penn to acquire Pennsylvanias William Penn for $127m (Retail Banker International)
Nov-01-24 11:33AM	Mid Penn Bancorp strikes deal to acquire rival, expand in Philadelphia (American Banker)
07:08AM	Mid Penn Bancorp, Inc. Announces Pricing of $70 Million Offering of Common Stock (Business Wire)
06:01AM	Mid Penn Bancorp, Inc. to Acquire William Penn Bancorporation (Business Wire)
Oct-23-24 06:25PM	Mid Penn Bancorp (MPB) Q3 Earnings and Revenues Beat Estimates (Zacks)
05:10PM	Mid Penn Bancorp, Inc. Reports Third Quarter Earnings Beat and Declares 56th Consecutive Quarterly Dividend (Business Wire)
Sep-12-24 12:00PM	All You Need to Know About Mid Penn Bancorp (MPB) Rating Upgrade to Strong Buy (Zacks)
Jul-24-24 06:25PM	Mid Penn Bancorp (MPB) Beats Q2 Earnings and Revenue Estimates (Zacks) +5.74%
05:16PM	Mid Penn Bancorp, Inc. Reports Second Quarter Earnings Beat and Declares 55th Consecutive Quarterly Dividend (Business Wire)
Jun-18-24 08:44AM	Is the Options Market Predicting a Spike in Mid Penn Bancorp (MPB) Stock? (Zacks)
May-08-24 04:32AM	Insiders are Buying These 10 Undervalued Bank Stocks (Insider Monkey)
Apr-29-24 04:06PM	10 Undervalued Stocks with Latest Insider Purchases (Insider Monkey)
09:54PM	Loading…
Apr-24-24 09:54PM	MPB Stock Earnings: Mid Penn Bancorp Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:56PM	Mid Penn Bancorp Inc Surpasses Analyst Expectations with Strong Q1 Earnings (GuruFocus.com)
04:27PM	Mid Penn Bancorp, Inc. Reports First Quarter Earnings Beat and Declares 54th Consecutive Quarterly Dividend (Business Wire)
Jan-26-24 10:40AM	Mid Penn Bancorp (MPB) Q4 Earnings and Revenues Surpass Estimates (Zacks)
09:28AM	Mid Penn Bancorp, Inc. Reports Fourth Quarter Earnings and Declares Quarterly Dividend (Business Wire)
06:51AM	Mid Penn Bancorp Inc Reports Robust Earnings Growth and Declares Dividend (GuruFocus.com)
Jan-19-24 11:57AM	Mid Penn Bank Promotes Jordan Space to President of the Private Bank and Chief Operating Officer of the Company (Business Wire)
Jan-18-24 05:41PM	Mid Penn Bank Promotes Scott Micklewright to President of the Commercial and Consumer Bank (Business Wire)
Jan-12-24 10:32AM	Mid Penn Bancorp, Inc. Appoints Justin T. Webb as Chief Financial Officer (Business Wire)
Oct-25-23 06:28PM	Mid Penn Bancorp Inc (MPB) Reports Q3 2023 Earnings and Declares Dividend (GuruFocus.com)
06:05PM	Mid Penn Bancorp (MPB) Q3 Earnings Lag Estimates (Zacks)
04:15PM	Mid Penn Bancorp, Inc. Reports Third Quarter Earnings And Declares Dividend (GlobeNewswire)
Oct-23-23 06:15PM	SmarFinancial (SMBK) Q3 Earnings and Revenues Miss Estimates (Zacks)
Oct-13-23 09:40AM	Are Investors Undervaluing Mid Penn Bancorp (MPB) Right Now? (Zacks)
Oct-05-23 06:51AM	Here's Why Mid Penn Bancorp (MPB) Stock a Solid Pick Now (Zacks)
Aug-04-23 06:06AM	Should You Buy Mid Penn Bancorp, Inc. (NASDAQ:MPB) For Its Upcoming Dividend? (Simply Wall St.)
Aug-01-23 06:03AM	Mid Penn Bancorp (NASDAQ:MPB) Is Due To Pay A Dividend Of $0.20 (Simply Wall St.)
Jul-27-23 07:25PM	Mid Penn Bancorp (MPB) Lags Q2 Earnings Estimates (Zacks)
06:03PM	Mid Penn Bancorp, Inc. Reports Second Quarter Earnings and Declares Dividend (GlobeNewswire)
Jul-25-23 08:45AM	Atlantic Union (AUB) Beats Q2 Earnings and Revenue Estimates (Zacks)
Jul-20-23 10:02AM	Analysts Estimate ConnectOne Bancorp (CNOB) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-19-23 10:01AM	Analysts Estimate Mid Penn Bancorp (MPB) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jun-05-23 09:13AM	Mid Penn Bancorp, Inc.'s (NASDAQ:MPB) top owners are individual investors with 46% stake, while 42% is held by institutions (Simply Wall St.)
May-25-23 04:37PM	Mid Penn Bancorp, Inc. Announces Appointment of Joel L. Frank to Board of Directors (GlobeNewswire)
04:37PM	Mid Penn Bancorp, Inc. Announces Appointment of Albert J. Evans to Board of Directors (GlobeNewswire)
May-22-23 06:15AM	Mid Penn Bancorp, Inc. Completes Acquisition of Brunswick Bancorp (GlobeNewswire)
May-14-23 08:03AM	Mid Penn Bancorp Independent Director Acquires 12% More Stock \ (Simply Wall St.)
May-04-23 06:04AM	There's A Lot To Like About Mid Penn Bancorp's (NASDAQ:MPB) Upcoming US$0.20 Dividend (Simply Wall St.)
Apr-28-23 07:35PM	Mid Penn Bancorp (MPB) Misses Q1 Earnings and Revenue Estimates (Zacks)
06:11PM	Mid Penn Bancorp, Inc. Reports First Quarter Earnings and Declares Dividend (GlobeNewswire)
Apr-25-23 01:45PM	Mid Penn Bancorp, Inc. and Brunswick Bancorp Receive Regulatory and Shareholder Approvals for Merger (GlobeNewswire)
Mar-14-23 12:05PM	Mid Penn Bancorp, Inc. Announces Appointment of New Board Member (GlobeNewswire)
Feb-25-23 07:09AM	We Ran A Stock Scan For Earnings Growth And Mid Penn Bancorp (NASDAQ:MPB) Passed With Ease (Simply Wall St.)
Feb-04-23 07:41AM	Here's What We Like About Mid Penn Bancorp's (NASDAQ:MPB) Upcoming Dividend (Simply Wall St.)
Feb-02-23 05:27AM	The Independent Director of Mid Penn Bancorp, Inc. (NASDAQ:MPB), Theodore Mowery, Just Bought 9.2% More Shares (Simply Wall St.)
Jan-29-23 07:19AM	Mid Penn Bancorp (NASDAQ:MPB) Has Affirmed Its Dividend Of $0.20 (Simply Wall St.)
Jan-27-23 05:29AM	Mid Penn Bancorp Full Year 2022 Earnings: In Line With Expectations (Simply Wall St.)
Jan-25-23 03:15PM	Mid Penn Bancorp (MPB) Q4 Earnings and Revenues Top Estimates (Zacks)
01:29PM	Mid Penn Bancorp, Inc. Reports Fourth Quarter Earnings and Declares Dividend (GlobeNewswire)
Jan-19-23 04:20AM	Best Value Stocks to Buy for January 19th (Zacks)
Jan-05-23 07:00AM	Investing in Mid Penn Bancorp (NASDAQ:MPB) five years ago would have delivered you a 2.4% gain (Simply Wall St.)
Jan-02-23 09:35AM	Mid Penn Bancorp (MPB) Loses -9.04% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Dec-28-22 10:10AM	5 Reasons to Invest in Mid Penn Bancorp (MPB) Stock Right Now (Zacks)
Dec-22-22 08:24AM	Mid Penn (MPB) Agrees to Acquire Brunswick for $53.9 Million (Zacks)
Dec-20-22 04:13PM	Mid Penn Bancorp, Inc. Signs Definitive Agreement to Acquire Brunswick Bancorp (GlobeNewswire)
Dec-08-22 10:00AM	Best Momentum Stock to Buy for December 8th (Zacks)
Dec-02-22 08:51AM	Individual investors account for 48% of Mid Penn Bancorp, Inc.'s (NASDAQ:MPB) ownership, while institutions account for 40% (Simply Wall St.)
Nov-17-22 08:50AM	What Makes Mid Penn Bancorp (MPB) a Good Fit for "Trend Investing" (Zacks)
Nov-05-22 08:21AM	Be Sure To Check Out Mid Penn Bancorp, Inc. (NASDAQ:MPB) Before It Goes Ex-Dividend (Simply Wall St.)
Nov-01-22 08:50AM	Mid Penn Bancorp (MPB) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Oct-26-22 03:45PM	Mid Penn Bancorp (MPB) Q3 Earnings and Revenues Surpass Estimates (Zacks)
02:23PM	Mid Penn Bancorp, Inc. Reports Third Quarter Earnings and Declares Dividend (GlobeNewswire)
Oct-14-22 03:47AM	Mid Penn Bancorp (MPB) Stock Jumps 5.5%: Will It Continue to Soar? (Zacks)
Oct-06-22 01:27PM	Mid Penn Bank to Open New Financial Center in Lehigh County (GlobeNewswire)
Sep-22-22 02:31PM	Mid Penn Bank to Open New Financial Center in Montgomery County (GlobeNewswire)
Aug-31-22 09:55AM	Mid Penn Bancorp (MPB) Could Find Support Soon, Here's Why You Should Buy the Stock Now (Zacks)
Aug-08-22 06:24AM	Trade Alert: The Independent Director Of Mid Penn Bancorp, Inc. (NASDAQ:MPB), Robert Abel, Has Just Spent US$86k Buying 15% More Shares (Simply Wall St.)
Aug-05-22 06:21AM	Mid Penn Bancorp, Inc. (NASDAQ:MPB) Passed Our Checks, And It's About To Pay A US$0.20 Dividend (Simply Wall St.)
Jul-31-22 08:31AM	Mid Penn Bancorp (NASDAQ:MPB) Is Paying Out A Dividend Of $0.20 (Simply Wall St.)
Jul-29-22 07:48AM	Investing in Mid Penn Bancorp (NASDAQ:MPB) three years ago would have delivered you a 22% gain (Simply Wall St.)
Jul-27-22 03:15PM	Mid Penn Bancorp (MPB) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
01:47PM	Mid Penn Bancorp, Inc. Reports Second Quarter Earnings and Declares Dividend (GlobeNewswire)
Jun-30-22 08:43AM	New Strong Buy Stocks for June 30th (Zacks)
07:44AM	Best Income Stocks to Buy for June 30th (Zacks)
Jun-19-22 08:12AM	Here's What Mid Penn Bancorp, Inc.'s (NASDAQ:MPB) Shareholder Ownership Structure Looks Like (Simply Wall St.)
May-12-22 02:47PM	Mid Penn Bancorp, Inc. Hires Allison Johnson as SEVP, Chief Financial Officer (GlobeNewswire)
May-11-22 03:02PM	Mid Penn Bank Hires Jordan Space as EVP, Chief Corporate Development Officer (GlobeNewswire)
May-05-22 06:15AM	Mid Penn Bancorp, Inc. (NASDAQ:MPB) Passed Our Checks, And It's About To Pay A US$0.20 Dividend (Simply Wall St.)
May-01-22 08:32AM	Mid Penn Bancorp (NASDAQ:MPB) Is Due To Pay A Dividend Of US$0.20 (Simply Wall St.)
Apr-27-22 06:25PM	Mid Penn Bancorp (MPB) Q1 Earnings and Revenues Surpass Estimates (Zacks)

Mid Penn Bancorp, Inc. is a financial holding company, which engages in the provision of commercial banking and financial services. Its services include banking, financing, and planning to individuals, businesses, and nonprofit organizations. The company was founded in 1868 and is headquartered in Harrisburg, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Noone John E	Director	Nov 19 '25	Buy	28.28	2,000	56,561	47,400	Nov 20 11:53 AM
Noone John E	Director	Oct 27 '25	Buy	29.51	2,000	59,025	45,400	Oct 28 11:42 AM
MOWERY THEODORE W	Director	Sep 30 '25	Buy	28.64	70	2,005	39,694	Oct 01 02:53 PM
Frank Joel L.	Director	Sep 30 '25	Buy	28.64	88	2,520	9,178	Oct 01 02:52 PM
Brumbaugh Kimberly J	Director	Sep 30 '25	Buy	28.64	88	2,520	10,260	Oct 01 02:49 PM
Evans Albert J.	Director	Sep 30 '25	Buy	28.64	349	9,995	38,879	Oct 01 02:46 PM
De Soto Matthew G	Director	Sep 30 '25	Buy	28.64	280	8,019	112,754	Oct 01 02:43 PM
Abel Robert A	Director	Sep 30 '25	Buy	28.64	18	516	7,586	Oct 01 02:41 PM
Noone John E	Director	Jul 29 '25	Buy	27.25	2,000	54,492	3,200	Jul 30 09:50 AM
MOWERY THEODORE W	Director	Jun 30 '25	Buy	28.20	71	2,002	39,383	Jul 02 10:41 AM
Abel Robert A	Director	Jun 30 '25	Buy	28.20	17	479	7,518	Jul 02 10:39 AM
De Soto Matthew G	Director	Jun 30 '25	Buy	28.20	283	7,981	112,354	Jul 02 10:37 AM
Brumbaugh Kimberly J	Director	Jun 30 '25	Buy	28.20	88	2,482	10,111	Jul 02 10:35 AM
Frank Joel L.	Director	Jun 30 '25	Buy	28.20	88	2,482	9,059	Jul 02 10:32 AM
Evans Albert J.	Director	Jun 30 '25	Buy	28.20	354	9,983	38,496	Jul 02 10:24 AM
RITRIEVI RORY G	President and CEO	Jun 12 '25	Buy	26.64	93	2,477	10,905	Jun 13 02:46 PM
De Soto Matthew G	Director	Jun 05 '25	Buy	25.91	1,928	49,962	112,071	Jun 06 12:43 PM
De Soto Matthew G	Director	May 23 '25	Buy	26.66	1,875	49,990	110,013	May 27 01:17 PM
Noone John E	Director	May 23 '25	Buy	26.60	1,000	26,600	43,400	May 27 01:14 PM
Noone John E	Director	May 20 '25	Buy	28.23	1,000	28,234	42,400	May 22 11:07 AM
Evans Albert J.	Director	May 13 '25	Buy	28.87	250	7,218	38,104	May 19 02:32 PM
De Soto Matthew G	Director	May 16 '25	Buy	28.10	3,560	100,032	108,138	May 19 12:12 PM
Hudson Brian Arden Sr.	Director	May 08 '25	Sale	28.83	500	14,413	6,914	May 09 09:00 AM
Evans Albert J.	Director	Apr 28 '25	Buy	28.61	1,058	30,269	37,554	Apr 30 04:18 PM
Evans Albert J.	Director	Apr 29 '25	Buy	28.65	300	8,594	37,854	Apr 30 04:18 PM
Noone John E	Director	Apr 28 '25	Buy	28.18	1,000	28,177	41,400	Apr 30 09:47 AM
Abel Robert A	Director	Mar 31 '25	Buy	25.91	20	518	6,447	Apr 01 03:56 PM
Brumbaugh Kimberly J	Director	Mar 31 '25	Buy	25.91	97	2,513	8,958	Apr 01 03:54 PM
De Soto Matthew G	Director	Mar 31 '25	Buy	25.91	309	8,006	103,579	Apr 01 03:52 PM
Evans Albert J.	Director	Mar 31 '25	Buy	25.91	386	10,001	35,497	Apr 01 03:49 PM
Frank Joel L.	Director	Mar 31 '25	Buy	25.91	97	2,513	7,939	Apr 01 03:44 PM
MOWERY THEODORE W	Director	Mar 31 '25	Buy	25.91	77	1,995	38,052	Apr 01 03:37 PM
RITRIEVI RORY G	President and CEO	Feb 14 '25	Buy	29.56	3,365	99,476	10,750	Feb 14 01:23 PM
De Soto Matthew G	Director	Feb 04 '25	Buy	29.07	2,575	74,847	103,162	Feb 05 01:31 PM
De Soto Matthew G	Director	Feb 04 '25	Buy	28.86	1,035	29,873	3,327	Feb 05 01:31 PM
RITRIEVI RORY G	President and CEO	Jan 27 '25	Buy	30.05	3,050	91,639	7,385	Jan 28 12:06 PM
Abel Robert A	Director	Dec 31 '24	Buy	28.84	17	490	6,384	Jan 02 11:23 AM
Evans Albert J.	Director	Dec 31 '24	Buy	28.84	347	10,007	35,084	Jan 02 11:21 AM
Frank Joel L.	Director	Dec 31 '24	Buy	28.84	87	2,509	7,813	Jan 02 11:18 AM
De Soto Matthew G	Director	Dec 31 '24	Buy	28.84	278	8,018	100,587	Jan 02 11:16 AM
Brumbaugh Kimberly J	Director	Dec 31 '24	Buy	28.84	87	2,509	8,809	Jan 02 11:14 AM
MOWERY THEODORE W	Director	Dec 31 '24	Buy	28.84	69	1,990	37,743	Jan 02 11:11 AM
Gathagan Maureen M.	Director	Dec 03 '24	Buy	31.80	9	286	10,224	Dec 04 03:02 PM

Open in Screener

INTT

Intest Corp

Nov 20 • 01:29PM ET

7.39

-0.06 -0.87 %

Technology • Semiconductor Equipment & Materials • USA • AMEX

Peers: TER AEHR COHU ONTO CAMT KLIC FORM MMSI UCTT AXTI

Index	-	P/E	-	EPS (ttm)	-0.19	Insider Own	13.45%	Shs Outstand	12.48M	Perf Week	-2.83%
Market Cap	92.19M	Forward P/E	24.62	EPS next Y	0.30	Insider Trans	0.36%	Shs Float	10.80M	Perf Month	-8.83%
Enterprise Value	89.93M	PEG	-	EPS next Q	0.13	Inst Own	57.36%	Short Float	0.19%	Perf Quarter	5.50%
Income	-2.27M	P/S	0.78	EPS this Y	-95.10%	Inst Trans	-1.04%	Short Ratio	0.45	Perf Half Y	26.46%
Sales	117.61M	P/B	0.90	EPS next Y	1100.00%	ROA	-1.48%	Short Interest	0.02M	Perf YTD	-14.03%
Book/sh	8.16	P/C	4.37	EPS next 5Y	-0.66%	ROE	-2.24%	52W High	9.77 -24.41%	Perf Year	2.57%
Cash/sh	1.69	P/FCF	9.54	EPS past 3/5Y	-29.66% 1.12%	ROIC	-2.02%	52W Low	5.24 40.94%	Perf 3Y	-27.95%
Dividend Est.	-	EV/EBITDA	24.24	Sales past 3/5Y	15.47% 16.59%	Gross Margin	39.16%	Volatility	7.06% 6.41%	Perf 5Y	46.24%
Dividend TTM	-	EV/Sales	0.76	EPS Y/Y TTM	-204.45%	Oper. Margin	-1.94%	ATR (14)	0.50	Perf 10Y	82.35%
Dividend Ex-Date	Dec 06, 2012	Quick Ratio	1.45	Sales Y/Y TTM	-2.20%	Profit Margin	-1.93%	RSI (14)	41.23	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	2.31	EPS Q/Q	-290.10%	SMA20	-8.99%	Beta	1.65	Target Price	11.00
Payout	0.00%	Debt/Eq	0.18	Sales Q/Q	-13.33%	SMA50	-8.67%	Rel Volume	0.55	Prev Close	7.45
Employees	425	LT Debt/Eq	0.10	Earnings	Nov 05 BMO	SMA200	1.35%	Avg Volume	46.17K	Price	7.39
IPO	Jun 17, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	-146.19% -9.84%	Trades		Volume	16,246	Change	-0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-15-25	Resumed	Lake Street	Buy	$8
Jan-02-25	Upgrade	Northland Capital	Market Perform → Outperform	$13
Aug-05-24	Downgrade	Northland Capital	Outperform → Market Perform
Nov-21-22	Initiated	Northland Capital	Outperform	$20
Feb-08-19	Initiated	Lake Street	Buy	$9
Oct-06-17	Initiated	Dougherty & Company	Buy	$11

Nov-07-25 10:00AM	inTest Corp (INTT) Q3 2025 Earnings Call Highlights: Record Orders Amid Revenue Challenges (GuruFocus.com)
Nov-05-25 07:25AM	inTest Corporation (INTT) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:15AM	Meta Slumps on AI Spending, Echoing 2022 Metaverse Rout (Bloomberg)
Nov-04-25 08:46AM	Earnings To Watch: inTest Corp (INTT) Reports Q3 2025 Result (GuruFocus.com)
Oct-03-25 08:50AM	Fast-paced Momentum Stock inTest (INTT) Is Still Trading at a Bargain (Zacks)
09:40AM	Loading…
Sep-03-25 09:40AM	Should Value Investors Buy inTest (INTT) Stock? (Zacks)
Aug-29-25 08:50AM	Why Fast-paced Mover inTest (INTT) Is a Great Choice for Value Investors (Zacks)
Aug-22-25 10:40AM	Keysight Completes First PSA Certified Level 4 Security Evaluation (Zacks)
Aug-13-25 08:50AM	Fast-paced Momentum Stock inTest (INTT) Is Still Trading at a Bargain (Zacks)
Aug-08-25 09:40AM	Are Investors Undervaluing inTest (INTT) Right Now? (Zacks)
Aug-06-25 07:25AM	inTest Corporation (INTT) Q2 Earnings and Revenues Surpass Estimates (Zacks)
06:25AM	InTest Corporation Receives $2.6 Million Defense Industry Order (Business Wire)
06:15AM	InTest Reports Orders Improved 10% and Gross Margin Expanded 110 basis points Sequentially to 42.6% for Second Quarter 2025 (Business Wire)
Aug-05-25 10:33AM	inTest Corp (INTT) Q2 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-23-25 04:15PM	InTest Schedules Second Quarter 2025 Financial Results Conference Call and Webcast (Business Wire)
11:16AM	Loading…
Jun-25-25 11:16AM	Camtek (CAMT) Moves 9.0% Higher: Will This Strength Last? (Zacks)
Jun-12-25 08:30AM	InTest Corporation Announces Leadership Transition in Environmental Technologies Division (Business Wire)
May-09-25 08:34AM	Are Options Traders Betting on a Big Move in InTest Stock? (Zacks)
May-03-25 03:02AM	inTest Corp (INTT) Q1 2025 Earnings Call Highlights: Navigating Market Challenges with ... (GuruFocus.com)
May-02-25 12:18PM	inTEST Corporation (INTT) Q1 2025 Earnings Call Transcript (Seeking Alpha)
07:25AM	InTest Corporation (INTT) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
06:15AM	InTest Reports $26.6 Million in Revenue and 41.5% Gross Margin for First Quarter 2025 (Business Wire)
May-01-25 09:34AM	inTest Corp (INTT) Q1 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Apr-17-25 04:15PM	InTest Schedules First Quarter 2025 Financial Results Conference Call and Webcast (Business Wire)
Apr-15-25 02:15PM	InTest Recognized for Excellence by Texas Instruments (Business Wire)
Mar-27-25 10:08AM	Are Options Traders Betting on a Big Move in inTest (INTT) Stock? (Zacks)
Mar-26-25 04:15PM	InTest Rings NYSE Opening Bell with Launch of VISION 2030 Strategy (Business Wire)
08:30AM	InTest Announces VISION 2030 Strategy for Growth (Business Wire)
Mar-19-25 04:15PM	inTEST to Host Investor & Analyst Strategy Briefing (Business Wire)
Mar-08-25 02:02AM	inTest Corp (INTT) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... (GuruFocus.com)
11:09PM	Loading…
Mar-07-25 11:09PM	Q4 2024 inTest Corp Earnings Call (Thomson Reuters StreetEvents)
07:25AM	InTest Corporation (INTT) Q4 Earnings and Revenues Surpass Estimates (Zacks)
06:20AM	inTEST Corporation Renews Stock Repurchase Plan (Business Wire)
06:15AM	inTEST Reports Fourth Quarter 2024 Revenue Grew 31% and Operating Income Increased 87% Year-over-Year (Business Wire)
Mar-06-25 07:10AM	inTest Corp (INTT) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-20-25 04:15PM	inTEST Schedules Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast (Business Wire) +5.51%
Feb-07-25 08:08AM	Why inTEST Corporation (INTT) Is Skyrocketing So Far In 2025? (Insider Monkey) -5.08%
Jan-15-25 09:00PM	inTEST EMS Products Signs General Bussan Co., Ltd. as Exclusive Distributor in Japan (Business Wire) +9.18%
08:11AM	inTEST partners with Prodigy USA for cannabis oil extraction products (TipRanks)
Jan-14-25 08:30AM	inTEST Corporation Expands Distributor Channels to Broaden Geographic Reach and Increase Target Market Share (Business Wire)
08:00AM	Prodigy Processing Solutions Announces Strategic Partnership with inTEST Thermal Solutions (PR Newswire)
Jan-10-25 08:30AM	inTEST Corporation to Present at the Needham Growth Conference (Business Wire)
Dec-25-24 09:40AM	Should Value Investors Buy inTest (INTT) Stock? (Zacks)
Dec-16-24 08:27AM	Heres Why Intest (INTT) Detracted in Q3 (Insider Monkey)
Dec-12-24 08:50AM	Why Fast-paced Mover inTest (INTT) Is a Great Choice for Value Investors (Zacks)
Dec-09-24 09:40AM	Are Investors Undervaluing inTest (INTT) Right Now? (Zacks)
Dec-05-24 04:15PM	inTEST Corporation to Participate in the 13th Annual NYC Summit (Business Wire)
Dec-04-24 09:51AM	Are Options Traders Betting on a Big Move in inTest (INTT) Stock? (Zacks)
Dec-03-24 08:30AM	Sidoti Events, LLC's Virtual December Small-Cap Conference (ACCESSWIRE) +5.02%
Nov-25-24 08:50AM	Despite Fast-paced Momentum, inTest (INTT) Is Still a Bargain Stock (Zacks)
Nov-22-24 09:40AM	Should Value Investors Buy inTest (INTT) Stock? (Zacks)
Nov-21-24 04:15PM	inTEST Corporation to Participate in Upcoming Investor Conferences (Business Wire)
Nov-13-24 04:15PM	inTEST Corporation to Present at the Southwest IDEAS Conference (Business Wire)
Nov-06-24 12:00PM	inTest (INTT) Upgraded to Strong Buy: Here's What You Should Know (Zacks) +7.53%
09:40AM	Are Investors Undervaluing inTest (INTT) Right Now? (Zacks)
08:50AM	inTest (INTT) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Nov-02-24 03:01AM	inTest Corp (INTT) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with ... (GuruFocus.com)
Nov-01-24 11:04PM	Q3 2024 inTest Corp Earnings Call (Thomson Reuters StreetEvents)
07:25AM	InTest Corporation (INTT) Q3 Earnings Surpass Estimates (Zacks)
06:15AM	inTEST Achieves 46.3% Gross Margin for Third Quarter 2024 (Business Wire)
Oct-31-24 09:07AM	What To Expect From inTest Corp (INTT) Q3 2024 Earnings (GuruFocus.com)
Oct-25-24 08:30AM	inTEST Schedules Third Quarter 2024 Financial Results Conference Call and Webcast (Business Wire)
Oct-15-24 05:01PM	Chuck Royce's Strategic Acquisition of inTest Corp Shares (GuruFocus.com) -5.15%
Sep-20-24 08:00AM	iAccess Alpha's Buyside Best Ideas Virtual Fall Conference September 24-25, 2024 (ACCESSWIRE)
Sep-10-24 08:30AM	inTEST Corporation to Webcast Presentation at the iAccess Alpha Virtual Conference (Business Wire) +5.61%
Aug-15-24 04:30PM	inTEST Corporation to Present at the Midwest IDEAS Conference (Business Wire) +9.30%
Aug-02-24 07:50AM	InTest Corporation (INTT) Q2 Earnings and Revenues Miss Estimates (Zacks) -22.71%
06:30AM	inTEST Reports 4% Revenue Growth for Second Quarter 2024 (Business Wire)
Jul-25-24 04:15PM	inTEST Schedules Second Quarter 2024 Financial Results Conference Call and Webcast (Business Wire)
Jun-20-24 04:15PM	inTEST Corporation to Participate in the Northland Growth Conference and Present at the Noble Emerging Growth Conference (Business Wire)
Jun-17-24 05:00PM	inTEST Corporation Launches Innovative Hover Sense Non-Contact Probe Testing Technology for Electric Vehicle Battery Testing (Business Wire)
May-29-24 04:15PM	inTEST Corporation to Present at the East Coast IDEAS Conference (Business Wire)
May-22-24 11:04AM	Do Options Traders Know Something About inTEST (INTT) Stock We Don't? (Zacks)
May-07-24 09:46AM	inTEST Corporation (AMEX:INTT) Q1 2024 Earnings Call Transcript (Insider Monkey) -7.70%
06:58AM	Q1 2024 inTest Corp Earnings Call (Thomson Reuters StreetEvents)
03:10AM	inTest Corp (INTT) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and ... (GuruFocus.com)
May-06-24 05:58PM	inTest Corp Reports Q1 2024 Earnings: Revenue Aligns with Analyst Projections (GuruFocus.com)
04:07PM	inTEST Reports $29.8 Million in Revenue for First Quarter 2024 (Business Wire)
May-03-24 08:30AM	inTEST Extends Maturity Date of Borrowing Agreement to 2031 (Business Wire)
Apr-29-24 10:30AM	inTEST Corporation Launches Leading-Edge Benchtop Temperature Test System (Business Wire)
Apr-24-24 11:15AM	What Is the Best $10 Stock to Buy in April? 3 Top Picks (InvestorPlace)
Apr-22-24 04:15PM	inTEST Schedules First Quarter 2024 Financial Results Conference Call and Webcast (Business Wire)
Apr-02-24 04:15PM	inTEST Corporation to Present at the LD Micro Invitational Conference (Business Wire)
Apr-01-24 06:15PM	InTest Corporation (INTT) Rises As Market Takes a Dip: Key Facts (Zacks)
Mar-29-24 05:31AM	inTest Corp (INTT) Delivers Record Revenue and Net Income, Aligning with Analyst Projections (GuruFocus.com)
01:23AM	Q4 2023 inTest Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-27-24 05:07PM	inTEST Reports Record $123.3 Million in Revenue and Net Income of $9.3 Million for Full Year 2023 (Business Wire) +16.53%
08:08AM	inTEST Announces Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast (Business Wire)
Mar-20-24 09:30AM	Wall Street Analysts Think inTest (INTT) Is a Good Investment: Is It? (Zacks)
Mar-12-24 04:17PM	inTEST Expands Electronic Test Capabilities with Acquisition of Alfamation S.p.A. (Business Wire)
04:15PM	inTEST to Restate Third Quarter and First Nine Months 2023 Financial Statements (Business Wire)
10:30AM	Sidoti Events, LLC's Virtual March Small-Cap Conference (ACCESSWIRE)
Feb-29-24 05:51PM	inTest Corp (INTT) Issues Preliminary Q4 2023 Results and 2024 Outlook (GuruFocus.com)
05:12PM	inTEST Delays Fourth Quarter and Full Year 2023 Earnings Release and Investor Conference Call; Provides Preliminary Fourth Quarter Results and 2024 Guidance (Business Wire)
09:30AM	inTest Corporation (INTT) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Feb-21-24 06:00PM	InTest Corporation (INTT) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Feb-15-24 08:30AM	inTEST Announces Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast (Business Wire)
Feb-14-24 02:45AM	Jim Simons' Renaissance Technologies Adds Shares in inTest Corp (GuruFocus.com) +5.11%
Feb-09-24 06:00PM	InTest Corporation (INTT) Outperforms Broader Market: What You Need to Know (Zacks)
Jan-29-24 06:00PM	InTest Corporation (INTT) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)

InTest Corp. engages in the supply of precision-engineered solutions for manufacturing and testing across a wide range of markets including automotive, defense, aerospace, electronics, fiber optic, machining, medical, telecom, and semiconductors. It operates through the Thermal Products and Electromechanical Solutions (EMS) business segments. The Thermal Products segment designs, manufactures, and markets tester interface products. The EMS segment is composed of the manufacturing operations in New Jersey and California. The company was founded by Stuart F. Daniels, Daniel J. Graham, and Alyn R. Holt in September 1981 and is headquartered in Mount Laurel, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maginnis Gerald J.	Director	Nov 19 '25	Buy	7.44	6,000	44,640	84,057	Nov 20 09:24 AM
DEWS JOSEPH W IV	Director	May 12 '25	Buy	5.86	4,000	23,440	118,250	May 14 04:29 PM
Maginnis Gerald J.	Director	May 06 '25	Buy	5.78	7,557	43,679	78,057	May 07 04:30 PM
Grant Richard N. Jr.	President & CEO	Mar 10 '25	Sale	7.48	2,688	20,106	162,241	Mar 12 05:37 PM
Grant Richard N. Jr.	President & CEO	Mar 11 '25	Sale	7.57	1,184	8,963	161,057	Mar 12 05:37 PM

Open in Screener

COSM

Cosmos Health Inc

Nov 20 • 01:33PM ET

0.6502

+0.0010 0.15 %

Healthcare • Medical Distribution • Greece • NASD

COSM Cosmos Health Inc daily Stock Chart

Peers: VRTX OPK CERS CHEK AUPH VNDA HOOK XOMA NNVC

| Held by: VXF

Index	-	P/E	-	EPS (ttm)	-0.71	Insider Own	28.10%	Shs Outstand	31.87M	Perf Week	-10.52%
Market Cap	22.70M	Forward P/E	-	EPS next Y	-	Insider Trans	6.04%	Shs Float	25.11M	Perf Month	-36.26%
Enterprise Value	42.23M	PEG	-	EPS next Q	-	Inst Own	3.48%	Short Float	0.79%	Perf Quarter	-22.70%
Income	-18.54M	P/S	0.38	EPS this Y	-	Inst Trans	12.83%	Short Ratio	0.27	Perf Half Y	46.84%
Sales	59.79M	P/B	0.90	EPS next Y	-	ROA	-27.67%	Short Interest	0.20M	Perf YTD	-2.81%
Book/sh	0.73	P/C	4.86	EPS next 5Y	-	ROE	-63.82%	52W High	1.32 -50.74%	Perf Year	-7.12%
Cash/sh	0.13	P/FCF	-	EPS past 3/5Y	63.35% 28.41%	ROIC	-63.34%	52W Low	0.28 132.13%	Perf 3Y	-78.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-1.09% 6.53%	Gross Margin	9.12%	Volatility	10.51% 10.68%	Perf 5Y	-99.23%
Dividend TTM	-	EV/Sales	0.71	EPS Y/Y TTM	58.81%	Oper. Margin	-22.48%	ATR (14)	0.09	Perf 10Y	-99.72%
Dividend Ex-Date	-	Quick Ratio	0.84	Sales Y/Y TTM	-	Profit Margin	-31.01%	RSI (14)	31.06	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.99	EPS Q/Q	61.57%	SMA20	-15.46%	Beta	4.40	Target Price	3.00
Payout	-	Debt/Eq	1.05	Sales Q/Q	37.86%	SMA50	-30.53%	Rel Volume	0.88	Prev Close	0.65
Employees	149	LT Debt/Eq	0.27	Earnings	Nov 17 BMO	SMA200	0.86%	Avg Volume	740.20K	Price	0.65
IPO	Jul 23, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	419,673	Change	0.15%

Nov-17-25 09:15AM	Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M (GlobeNewswire)
Oct-31-25 10:45AM	Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy (GlobeNewswire) -10.01%
Oct-21-25 12:10PM	Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million (GlobeNewswire)
Oct-16-25 08:00AM	Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) -12.80%
Oct-13-25 02:05PM	Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million (GlobeNewswire)
08:00AM	Loading…
Oct-10-25 08:00AM	Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility (GlobeNewswire)
Oct-03-25 03:56PM	Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units (GlobeNewswire)
Sep-29-25 08:00AM	Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation (GlobeNewswire)
Sep-25-25 08:00AM	Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL Pessaries Annually (GlobeNewswire)
Sep-22-25 08:00AM	Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue (GlobeNewswire) +15.39%
Sep-11-25 08:00AM	Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units (GlobeNewswire) +10.51%
Aug-18-25 12:45PM	Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025 (GlobeNewswire) -5.27%
Aug-12-25 09:50AM	Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy (GlobeNewswire)
Aug-07-25 09:25AM	Cosmos Health secures $300M financing facility to launch Ethereum strategy (TipRanks) -8.70%
Aug-06-25 09:20AM	Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy (GlobeNewswire) +30.98%
11:00AM	Loading…
Jun-25-25 11:00AM	Cosmos Health enters U.S. market with DolCas Biotech agreement (TipRanks)
Jun-24-25 10:55AM	Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech (GlobeNewswire)
May-15-25 02:30PM	RETRANSMISSION - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven (GlobeNewswire)
09:30AM	Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven (GlobeNewswire)
May-07-25 02:30PM	Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units (GlobeNewswire)
May-06-25 01:40PM	Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq (GlobeNewswire)
Apr-30-25 12:50PM	Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 (GlobeNewswire)
Apr-16-25 12:45PM	Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million (GlobeNewswire)
Apr-09-25 01:40PM	Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L (GlobeNewswire)
Apr-08-25 10:45AM	Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order (GlobeNewswire)
Feb-26-25 11:30AM	Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates (ACCESSWIRE)
Feb-18-25 08:30AM	Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 (ACCESSWIRE)
Feb-11-25 10:15AM	Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market (ACCESSWIRE) -10.28%
Feb-10-25 01:30PM	Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market (ACCESSWIRE)
09:45AM	Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations (ACCESSWIRE)
10:00AM	Loading…
Feb-07-25 10:00AM	Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility (ACCESSWIRE)
Feb-06-25 03:50PM	Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar (ACCESSWIRE)
Feb-05-25 11:05AM	Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market (ACCESSWIRE)
Jan-28-25 11:00AM	Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow (ACCESSWIRE) -11.39%
Jan-27-25 03:50PM	Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion (ACCESSWIRE)
Jan-23-25 03:35PM	Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait (ACCESSWIRE)
Jan-22-25 08:00AM	Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million (ACCESSWIRE) -17.08%
Jan-21-25 03:00PM	Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days (ACCESSWIRE) +8.47%
Jan-14-25 09:41AM	Cosmos Health secures exclusive distribution agreement with Virax Biolabs (TipRanks) +12.55%
Jan-13-25 09:20AM	Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries (ACCESSWIRE)
Dec-26-24 01:30PM	Cosmos Health Strengthens RandD Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology (ACCESSWIRE)
01:30PM	Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology (ACCESSWIRE)
Dec-23-24 09:25AM	Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000 (ACCESSWIRE) +6.02%
Nov-26-24 09:30AM	Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price (ACCESSWIRE)
Nov-18-24 08:00AM	Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets (ACCESSWIRE) +11.13%
Nov-15-24 10:20AM	Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M (ACCESSWIRE)
Nov-12-24 12:00PM	Cosmos Health Issues Letter to Shareholders (ACCESSWIRE) +7.09%
Nov-01-24 12:30PM	Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% (ACCESSWIRE) -5.32%
Sep-25-24 09:25AM	Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands (ACCESSWIRE) -10.27%
Sep-23-24 12:55PM	Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins (ACCESSWIRE) -8.18%
09:00AM	Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits (ACCESSWIRE)
Sep-19-24 03:40PM	Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion (ACCESSWIRE)
Sep-18-24 01:30PM	Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments (ACCESSWIRE)
Sep-17-24 11:45AM	Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price (ACCESSWIRE) +13.43%
Sep-16-24 08:30AM	Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. (PR Newswire)
08:30AM	Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar (ACCESSWIRE)
Aug-23-24 09:35AM	Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements (ACCESSWIRE)
Aug-21-24 10:20AM	Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits (ACCESSWIRE) +17.76%
Aug-20-24 12:20PM	Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023 (ACCESSWIRE) -15.08%
09:00AM	Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit (ACCESSWIRE)
Aug-08-24 01:00PM	Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market (ACCESSWIRE)
Aug-06-24 09:00AM	Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share (ACCESSWIRE) +15.00%
Jul-25-24 02:45PM	Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland (ACCESSWIRE) +5.79%
11:40AM	Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar (ACCESSWIRE)
Jul-24-24 10:55AM	Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity (ACCESSWIRE)
Jul-19-24 11:40AM	Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule (ACCESSWIRE)
Jul-18-24 03:45PM	Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units (ACCESSWIRE) -10.36%
Jul-10-24 03:45PM	Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market (ACCESSWIRE)
Jul-09-24 02:00PM	Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually (ACCESSWIRE)
Jul-03-24 01:05PM	Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE (ACCESSWIRE) -10.89%
Jul-02-24 03:30PM	Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months (ACCESSWIRE) -8.18%
Jul-01-24 11:20AM	Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains (ACCESSWIRE) +5.77%
Jun-28-24 08:12AM	Why Is Cosmos Health (COSM) Stock Up 65% Today? (InvestorPlace) +53.17%
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-27-24 03:45PM	Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units (ACCESSWIRE) +5.27%
Jun-18-24 10:00AM	Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent (ACCESSWIRE)
Jun-13-24 09:25AM	Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million (ACCESSWIRE)
May-24-24 04:30PM	Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q (ACCESSWIRE) +5.87%
May-17-24 10:15AM	Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand (ACCESSWIRE)
Apr-30-24 09:42AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Healthcare Stocks (InvestorPlace)
Apr-19-24 04:30PM	Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K (ACCESSWIRE) -20.39%
Mar-21-24 09:45AM	Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform (ACCESSWIRE) -7.78%
Mar-19-24 10:10AM	Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market (ACCESSWIRE)
Mar-18-24 09:25AM	Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders (ACCESSWIRE) -5.34%
Feb-29-24 09:25AM	Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million (ACCESSWIRE)
Feb-23-24 12:00AM	As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows (The Wall Street Journal)
Feb-21-24 11:50AM	Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price (ACCESSWIRE)
09:30AM	Taglich Brothers Initiates Coverage of Cosmos Health Inc. (GlobeNewswire)
Feb-20-24 09:25AM	Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company (ACCESSWIRE)
Feb-01-24 09:25AM	Taglich Brothers Initiates Coverage of Cosmos Health Inc. (ACCESSWIRE)
Jan-23-24 01:05PM	Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market (ACCESSWIRE)
Jan-18-24 09:25AM	Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio (ACCESSWIRE)
Dec-27-23 09:27AM	Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023 (ACCESSWIRE) +10.07%
Dec-20-23 09:15AM	Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X (ACCESSWIRE) -12.33%
Dec-18-23 09:15AM	Cosmos Health Announces Open Market Stock Purchases by the CEO (ACCESSWIRE) +8.49%
Dec-08-23 12:45PM	Cosmos Health to Participate at Capital Links 'Invest in Greece' Forum in New York (ACCESSWIRE) -7.89%
Dec-07-23 09:35AM	Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers (ACCESSWIRE) +11.76%
Dec-01-23 10:25AM	Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product (ACCESSWIRE) +8.65%
Nov-21-23 09:00AM	Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share (ACCESSWIRE) -6.36%
Oct-11-23 09:35AM	Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders (ACCESSWIRE) +12.71%

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Siokas Grigorios	Chief Executive Officer	Nov 19 '25	Buy	0.65	61,614	40,000	6,220,498	Nov 20 11:06 AM
Siokas Grigorios	Chief Executive Officer	May 23 '25	Buy	0.45	34,004	15,217	6,158,884	May 27 09:33 AM
Siokas Grigorios	Chief Executive Officer	May 22 '25	Buy	0.44	141,825	62,800	6,124,880	May 23 12:18 PM
Siokas Grigorios	Chief Executive Officer	May 21 '25	Buy	0.47	174,172	82,000	5,983,055	May 22 10:33 AM
Siokas Grigorios	Chief Executive Officer	May 20 '25	Buy	0.45	147,563	65,961	5,808,883	May 21 10:20 AM
Siokas Grigorios	Chief Executive Officer	May 19 '25	Buy	0.43	79,254	34,000	5,661,320	May 20 09:51 AM
Siokas Grigorios	Chief Executive Officer	Apr 24 '25	Buy	0.40	254,618	102,000	5,582,066	Apr 28 10:49 AM
Siokas Grigorios	Chief Executive Officer	Apr 24 '25	Buy	0.40	177,234	71,000	5,327,448	Apr 25 10:07 AM
Siokas Grigorios	Chief Executive Officer	Apr 23 '25	Buy	0.40	205,000	82,000	5,150,214	Apr 24 09:48 AM
Siokas Grigorios	Chief Executive Officer	Apr 22 '25	Buy	0.36	175,000	63,000	4,945,214	Apr 23 10:43 AM
Siokas Grigorios	Chief Executive Officer	Apr 21 '25	Buy	0.32	654,912	208,000	4,770,214	Apr 22 09:59 AM
Siokas Grigorios	Chief Executive Officer	Mar 04 '25	Buy	0.53	85,714	45,000	4,115,302	Mar 05 11:05 AM
Siokas Grigorios	Chief Executive Officer	Mar 03 '25	Buy	0.49	132,572	65,000	4,029,588	Mar 04 12:32 PM
Siokas Grigorios	Chief Executive Officer	Feb 24 '25	Buy	0.56	354,296	200,000	3,897,016	Feb 25 09:49 AM
Siokas Grigorios	Chief Executive Officer	Jan 30 '25	Buy	0.66	51,414	34,000	4,255,103	Jan 31 09:46 AM
Siokas Grigorios	Chief Executive Officer	Jan 22 '25	Buy	0.77	38,900	30,000	4,203,689	Jan 23 09:39 AM
Siokas Grigorios	Chief Executive Officer	Jan 17 '25	Buy	0.86	29,158	25,000	4,164,789	Jan 21 09:35 AM
Siokas Grigorios	Chief Executive Officer	Jan 16 '25	Buy	0.83	47,904	40,000	4,135,631	Jan 17 09:00 AM
Siokas Grigorios	Chief Executive Officer	Jan 15 '25	Buy	0.80	62,500	50,000	4,087,727	Jan 16 08:45 AM
Siokas Grigorios	Chief Executive Officer	Jan 14 '25	Buy	0.69	87,247	60,000	4,025,227	Jan 15 09:00 AM
Siokas Grigorios	Chief Executive Officer	Jan 13 '25	Buy	0.61	163,666	100,000	3,937,980	Jan 14 08:24 AM
Terzis Georgios	Chief Financial Officer	Dec 20 '24	Buy	0.58	85,778	50,000	727,263	Dec 26 05:27 PM
Siokas Grigorios	Chief Executive Officer	Dec 20 '24	Buy	0.58	257,334	150,000	3,774,314	Dec 26 05:26 PM

Open in Screener

ITRM

Iterum Therapeutics Plc

Nov 20 • 01:33PM ET

0.3792

-0.0058 -1.51 %

Healthcare • Biotechnology • Ireland • NASD

ITRM Iterum Therapeutics Plc daily Stock Chart

Peers: QURE ENTA PTGX AXSM VSTM FATE CORT TVRD KPTI

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	1.58%	Shs Outstand	48.99M	Perf Week	-32.33%
Market Cap	20.01M	Forward P/E	-	EPS next Y	-0.38	Insider Trans	2.58%	Shs Float	47.29M	Perf Month	-45.60%
Enterprise Value	42.75M	PEG	-	EPS next Q	-0.09	Inst Own	2.56%	Short Float	2.86%	Perf Quarter	-49.03%
Income	-26.96M	P/S	51.32	EPS this Y	33.71%	Inst Trans	2.94%	Short Ratio	1.46	Perf Half Y	-59.27%
Sales	0.39M	P/B	-	EPS next Y	35.59%	ROA	-111.35%	Short Interest	1.35M	Perf YTD	-78.58%
Book/sh	-0.15	P/C	1.82	EPS next 5Y	22.77%	ROE	-	52W High	3.02 -87.44%	Perf Year	-73.30%
Cash/sh	0.21	P/FCF	-	EPS past 3/5Y	46.92% 29.27%	ROIC	-103.41%	52W Low	0.36 4.69%	Perf 3Y	-74.20%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-483.85%	Volatility	19.74% 8.97%	Perf 5Y	-95.29%
Dividend TTM	-	EV/Sales	109.63	EPS Y/Y TTM	62.61%	Oper. Margin	-5292.31%	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.96	Sales Y/Y TTM	-	Profit Margin	-6913.08%	RSI (14)	23.88	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.13	EPS Q/Q	35.53%	SMA20	-33.67%	Beta	2.99	Target Price	2.00
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-42.05%	Rel Volume	2.08	Prev Close	0.38
Employees	9	LT Debt/Eq	-	Earnings	Nov 14 BMO	SMA200	-60.11%	Avg Volume	926.63K	Price	0.38
IPO	May 25, 2018	Option/Short	No / Yes	EPS/Sales Surpr.	-77.78% -	Trades		Volume	1,236,276	Change	-1.51%

Date	Action	Analyst	Rating Change	Price Target Change
May-28-21	Upgrade	Gabelli & Co	Sell → Hold
Mar-15-21	Upgrade	H.C. Wainwright	Neutral → Buy	$2.50
Jun-02-20	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$7 → $2
Jan-21-20	Downgrade	Gabelli & Co	Buy → Sell
Dec-11-19	Downgrade	SVB Leerink	Outperform → Mkt Perform
Jun-21-19	Initiated	H.C. Wainwright	Buy	$17

Nov-14-25 04:01PM	Iterum Therapeutics PLC (ITRM) Q3 2025 Earnings Call Highlights: Launch Success and Financial ... (GuruFocus.com) -16.11% -22.95%
07:00AM	Iterum Therapeutics Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-07-25 08:00AM	Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025 (GlobeNewswire)
Oct-14-25 08:30AM	Iterum Therapeutics to Present Data at IDWeek 2025 (GlobeNewswire)
Sep-20-25 08:10AM	Iterum Therapeutics sees cash runway into 2026 (TipRanks)
08:00AM	Loading…
Sep-19-25 08:00AM	Iterum Therapeutics Provides Business Update (GlobeNewswire)
Aug-20-25 08:00AM	Iterum Therapeutics launches ORLYNVAH, the first and only oral penem antibiotic in the U.S. (GlobeNewswire) -8.56%
Aug-05-25 07:00AM	Iterum Therapeutics Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-29-25 08:00AM	Iterum Therapeutics to Report Second Quarter 2025 Financial Results on August 5, 2025 (GlobeNewswire)
Jul-02-25 04:30PM	Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-30-25 07:00AM	Iterum Names Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH Launch and Commercial Growth (GlobeNewswire)
Jun-25-25 07:00AM	Iterum Therapeutics Announces Publication of REASSURE Trial in NEJM Evidence (GlobeNewswire)
Jun-11-25 07:00AM	Iterum Therapeutics Announces Partnership for Commercialization Services (GlobeNewswire)
May-19-25 07:00AM	Iterum Therapeutics Announces Extension of Term of Promissory Note (GlobeNewswire)
May-14-25 03:08AM	Iterum Therapeutics PLC (ITRM) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ... (GuruFocus.com)
02:52AM	Loading…
02:52AM	Q1 2025 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
May-13-25 07:00AM	Iterum Therapeutics Reports First Quarter 2025 Financial Results (GlobeNewswire) -7.09%
May-06-25 07:00AM	Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire) -5.09%
Apr-30-25 04:30PM	Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares (GlobeNewswire) +5.66%
Apr-29-25 08:00AM	Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares (GlobeNewswire) -15.87%
Apr-14-25 08:00AM	Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics (GlobeNewswire)
Feb-08-25 02:06AM	Iterum Therapeutics PLC (ITRM) Q4 2024 Earnings Call Highlights: Navigating Financial ... (GuruFocus.com)
12:16AM	Q4 2024 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
Feb-07-25 07:00AM	Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Jan-31-25 08:00AM	Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025 (GlobeNewswire)
Nov-21-24 08:30AM	Iterum Therapeutics Regains Full Nasdaq Compliance (GlobeNewswire) +8.59%
Nov-15-24 02:10AM	Iterum Therapeutics PLC (ITRM) Q3 2024 Earnings Call Highlights: Strategic Moves Amid Financial ... (GuruFocus.com)
Nov-14-24 07:00AM	Iterum Therapeutics Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-11-24 08:00AM	Iterum Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024 (GlobeNewswire)
Oct-28-24 10:19AM	FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships (Benzinga) -23.94%
07:49AM	Loading…
07:49AM	FDA approves Iterums ORLYNVAH NDA for uUTI treatment (Pharmaceutical Technology)
05:00AM	Iterum Therapeutics to Host Morning Conference Call on U.S. FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections (PR Newswire)
Oct-25-24 11:03AM	Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections (GlobeNewswire) +60.68%
Oct-10-24 08:30AM	Iterum Therapeutics to Present Data at IDWeek 2024 (GlobeNewswire)
Oct-09-24 05:00PM	Iterum Therapeutics to Participate at the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire) -5.01%
Sep-24-24 10:33AM	Iterums oral sulopenem acceptance hinges on antibiotic stewardship efforts (Pharmaceutical Technology)
Sep-10-24 07:00AM	Iterum Therapeutics Provides Update on FDA Advisory Committee Discussion of Oral Sulopenem for the Treatment of uUTI in Adult Women (GlobeNewswire) -12.04%
Sep-06-24 04:30PM	Iterum Therapeutics to Present at the 26th Annual H.C. Wainwright Global Investment Conference (GlobeNewswire)
Aug-17-24 08:09AM	Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-14-24 07:00AM	Iterum Therapeutics Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-10-24 08:18AM	Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q2 2024 Earnings Call Transcript (Insider Monkey)
Aug-07-24 04:30PM	Iterum Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024 (GlobeNewswire)
Aug-06-24 05:30PM	Iterum Therapeutics Announces Expiration and Results of Rights Offering (GlobeNewswire)
Aug-02-24 08:00AM	Iterum Therapeutics Broadens Patent Estate for Oral Sulopenem (GlobeNewswire)
Jul-22-24 07:30AM	Iterum Therapeutics Commences Rights Offering (GlobeNewswire)
Jun-21-24 08:00AM	Iterum Therapeutics Announces FDA Advisory Committee Meeting to discuss NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections (GlobeNewswire) +7.83%
Jun-05-24 08:00AM	Iterum Therapeutics to Present Data at ASM Microbe 2024 (GlobeNewswire)
May-31-24 08:00AM	Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections (GlobeNewswire) +16.28%
May-14-24 08:21AM	Iterum Therapeutics plc (NASDAQ:ITRM) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-13-24 10:49PM	Q1 2024 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
11:53AM	ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024 (InvestorPlace)
07:00AM	Iterum Therapeutics Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-06-24 08:00AM	Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024 (GlobeNewswire)
Apr-29-24 08:00AM	Iterum Therapeutics Resubmits New Drug Application to U.S. Food and Drug Administration for Oral Sulopenem (GlobeNewswire) -7.78%
Apr-02-24 10:22AM	Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-29-24 12:09AM	Q4 2023 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
Mar-28-24 11:53AM	ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023 (InvestorPlace)
07:00AM	Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-21-24 04:30PM	Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024 (GlobeNewswire)
Mar-15-24 08:00AM	Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat (GlobeNewswire)
Mar-07-24 07:57AM	Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up (Zacks)
Mar-06-24 08:00AM	Iterum Therapeutics Provides Business Update (GlobeNewswire) +17.79%
Feb-01-24 03:03PM	Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC (GuruFocus.com)
Jan-30-24 07:00AM	Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections (PR Newswire) -11.73%
Dec-04-23 08:00AM	Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule (GlobeNewswire)
Nov-15-23 12:22PM	Iterum Therapeutics plc (NASDAQ:ITRM) Q3 2023 Earnings Call Transcript (Insider Monkey) +10.76%
12:08AM	Q3 2023 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents)
Nov-14-23 07:00AM	Iterum Therapeutics Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-07-23 08:30AM	Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023 (GlobeNewswire)
Oct-24-23 08:00AM	Iterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections (GlobeNewswire) +6.87%
Oct-12-23 09:15AM	Iterum Therapeutics to Present Data at IDWeek 2023 (GlobeNewswire)
Aug-11-23 10:10PM	Q2 2023 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents) +7.92% -9.17%
07:00AM	Iterum Therapeutics Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-04-23 05:00PM	Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023 (GlobeNewswire)
Jun-27-23 09:50AM	Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89% (Zacks)
Jun-21-23 08:35AM	Catalyst (CPRX) to Gain DMD Drug Licensing Rights From Santhera (Zacks)
Jun-12-23 06:23PM	Iterum Therapeutics to Present Data at ASM Microbe 2023 (GlobeNewswire)
May-12-23 07:00AM	Iterum Therapeutics Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-10-23 09:16AM	Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat (Zacks)
Apr-20-23 05:00PM	Iterum Therapeutics Presents Scientific Posters at ECCMID 2023 Highlighting Application of Desirability of Outcomes Ranking (DOOR) to two Registration Trials (GlobeNewswire) -5.04% -5.31%
Apr-13-23 12:00PM	All You Need to Know About Iterum Therapeutics PLC (ITRM) Rating Upgrade to Strong Buy (Zacks) +8.27%
Mar-18-23 02:06AM	Iterum Therapeutics plc (NASDAQ:ITRM) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-16-23 09:16PM	Q4 2022 Iterum Therapeutics PLC Earnings Call (Thomson Reuters StreetEvents) +15.00% -6.09%
07:00AM	Iterum Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-09-23 05:00PM	Iterum Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023 (GlobeNewswire) -8.70% -8.57%
Jan-11-23 06:00PM	Iterum Therapeutics Reports Employment Inducement Grant (GlobeNewswire) +12.50%
Dec-15-22 08:00AM	Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem (GlobeNewswire) +6.14%
Nov-10-22 07:00AM	Iterum Therapeutics Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-03-22 08:00AM	Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-20-22 07:30AM	Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections (GlobeNewswire) -5.56%
Oct-17-22 05:19PM	Iterum Therapeutics to Present Data at IDWeek 2022 (GlobeNewswire) +6.06%
Sep-19-22 07:30AM	Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem (GlobeNewswire)
Sep-07-22 09:15AM	Iterum Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire) +7.98%
Sep-01-22 04:15PM	Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule (GlobeNewswire) -6.51%
Aug-17-22 09:45AM	Iterum Therapeutics (NASDAQ:ITRM) Has Debt But No Earnings; Should You Worry? (Simply Wall St.) -19.24%
Aug-16-22 09:00PM	Iterum Therapeutics Announces Date of 1-for-15 Reverse Share Split (GlobeNewswire)
Aug-12-22 07:00AM	Iterum Therapeutics Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-11-22 02:31PM	Iterum Therapeutics Shares Are Surging - Read Why (Benzinga) +40.42%
07:30AM	Iterum Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA (GlobeNewswire)
Jul-06-22 04:30PM	Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.33%

Iterum Therapeutics Plc operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem. The company was founded by Corey N. Fishman on June 24, 2015 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dunne Michael W.	Director	Nov 18 '25	Buy	0.37	6,000	2,191	241,001	Nov 20 07:00 AM
Dunne Michael W.	Director	Aug 08 '25	Buy	0.72	15,000	10,854	235,001	Aug 12 07:00 AM

Open in Screener

IRIX

IRIDEX Corp

Nov 20 • 01:20PM ET

0.9505

-0.0013 -0.14 %

Healthcare • Medical Devices • USA • NASD

Peers: ALGN COO EW SYK BSX STAA CUTR ZBH GKOS PAVM

| Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	29.58%	Shs Outstand	17.05M	Perf Week	7.11%
Market Cap	16.34M	Forward P/E	-	EPS next Y	-	Insider Trans	3.27%	Shs Float	12.10M	Perf Month	-10.33%
Enterprise Value	21.56M	PEG	-	EPS next Q	-	Inst Own	16.49%	Short Float	2.28%	Perf Quarter	-23.35%
Income	-5.09M	P/S	0.32	EPS this Y	-	Inst Trans	-0.79%	Short Ratio	3.23	Perf Half Y	-4.01%
Sales	50.65M	P/B	-	EPS next Y	-	ROA	-17.39%	Short Interest	0.28M	Perf YTD	-43.42%
Book/sh	-0.08	P/C	2.93	EPS next 5Y	-	ROE	-139.29%	52W High	1.95 -51.26%	Perf Year	-45.99%
Cash/sh	0.32	P/FCF	-	EPS past 3/5Y	-16.95% 3.36%	ROIC	-60.29%	52W Low	0.78 21.55%	Perf 3Y	-52.95%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-3.35% 2.30%	Gross Margin	37.96%	Volatility	9.04% 5.82%	Perf 5Y	-46.60%
Dividend TTM	-	EV/Sales	0.43	EPS Y/Y TTM	55.26%	Oper. Margin	-6.04%	ATR (14)	0.07	Perf 10Y	-89.81%
Dividend Ex-Date	-	Quick Ratio	1.35	Sales Y/Y TTM	4.58%	Profit Margin	-10.04%	RSI (14)	42.39	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.94	EPS Q/Q	20.67%	SMA20	-6.99%	Beta	0.68	Target Price	2.00
Payout	-	Debt/Eq	1.02	Sales Q/Q	7.80%	SMA50	-13.08%	Rel Volume	0.62	Prev Close	0.95
Employees	93	LT Debt/Eq	0.80	Earnings	Nov 11 AMC	SMA200	-16.31%	Avg Volume	85.45K	Price	0.95
IPO	Feb 16, 1996	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	33,743	Change	-0.14%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-03-17	Resumed	ROTH Capital	Buy
Dec-21-16	Initiated	ROTH Capital	Buy
Jan-26-16	Initiated	Singular Research	Buy	$11.50
Jan-03-07	Initiated	First Albany	Buy	$15.50

Nov-12-25 12:00AM	IRIDEX Corp (IRIX) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Cost Management (GuruFocus.com) -19.82%
Nov-11-25 04:08PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance) +8.18%
04:05PM	Iridex Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Oct-28-25 04:05PM	Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025 (GlobeNewswire)
Sep-09-25 04:05PM	Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance (GlobeNewswire)
03:13AM	Loading…
Aug-13-25 03:13AM	IRIDEX Corp (IRIX) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Cost Challenges (GuruFocus.com) -9.23%
Aug-12-25 04:28PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Jul-29-25 04:05PM	Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire) -8.50%
Jun-30-25 06:45AM	Vicarious Surgical Announces Election of New Directors (Business Wire)
Jun-24-25 07:00AM	Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema (GlobeNewswire)
May-14-25 03:17AM	IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Investments ... (GuruFocus.com) -9.09%
May-13-25 04:33PM	Iridex: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 06:00PM	IRIDEX Changes Course (Seeking Alpha)
04:05PM	Loading…
Apr-30-25 04:05PM	Iridex to Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Apr-16-25 07:11PM	IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript) (Seeking Alpha)
Apr-14-25 04:05PM	Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025 (GlobeNewswire) +5.04%
Apr-09-25 04:05PM	Iridex to Host Strategic Vision Call on April 16, 2025 (GlobeNewswire) +10.67%
Mar-28-25 08:48AM	Q4 2024 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) +13.15%
03:04AM	IRIDEX Corp (IRIX) Q4 2024 Earnings Call Highlights: Strategic Investments and Revenue Growth ... (GuruFocus.com)
Mar-27-25 06:03PM	IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript (SeekingAlpha)
04:36PM	Iridex: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-19-25 09:15AM	Iridex Announces Strategic Investment in the Company (GlobeNewswire) -20.79%
Mar-14-25 07:00AM	Iridex Comments on Recent Stock Price Volatility (GlobeNewswire) +16.49%
Mar-13-25 05:00PM	Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025 (GlobeNewswire) -21.14%
Jan-14-25 07:24AM	Iridex: Q4 Sales To Match Performance Of Prior Year (RTT News)
07:00AM	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024 (GlobeNewswire)
Dec-18-24 04:05PM	Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management (GlobeNewswire)
08:14AM	Loading…
Nov-19-24 08:14AM	Iridex Comments on Changing Glaucoma Reimbursement Landscape (GlobeNewswire)
Nov-13-24 02:20AM	IRIDEX Corp (IRIX) Q3 2024 Earnings Call Highlights: Strategic Moves and Glaucoma Growth Amid ... (GuruFocus.com) +34.04%
Nov-12-24 04:40PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-04-24 04:05PM	Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 (GlobeNewswire) -5.02%
Oct-09-24 05:59PM	IRIDEX Corp (IRIX) Q2 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com) -6.96%
Oct-03-24 04:05PM	Iridex Appoints Patrick Mercer as Chief Executive Officer (GlobeNewswire)
Aug-08-24 09:57PM	IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024 (InvestorPlace)
06:15PM	Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:13PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Aug-05-24 08:00AM	Iridex Announces Convertible Note Financing (GlobeNewswire) -9.74%
Jul-30-24 04:05PM	Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
May-15-24 07:46AM	Q1 2024 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -13.96%
03:12AM	IRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ... (GuruFocus.com)
May-14-24 06:00PM	Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:55PM	Iridex: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-08-24 04:05PM	Iridex to Report First Quarter 2024 Financial Results on May 14, 2024 (GlobeNewswire)
Mar-27-24 10:39AM	IRIDEX Corporation (NASDAQ:IRIX) Q4 2023 Earnings Call Transcript (Insider Monkey) +17.53%
10:10AM	Q4 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents)
Mar-26-24 08:53PM	IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
06:05PM	Iridex (IRIX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
05:06PM	Iridex: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-20-24 04:05PM	Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024 (GlobeNewswire)
Feb-06-24 08:00AM	Iridex Corporation Receives European Patent on MicroPulse Technology (GlobeNewswire)
Jan-24-24 08:00AM	Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust (GlobeNewswire)
Jan-11-24 06:45PM	Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma (GlobeNewswire)
Dec-28-23 06:00PM	Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation (GlobeNewswire)
Nov-27-23 09:00AM	Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation (GlobeNewswire) +19.00%
Nov-14-23 05:06PM	Iridex: Q3 Earnings Snapshot (Associated Press Finance) -7.32% +6.84%
04:21PM	Iridex Reports Third Quarter 2023 Financial Results and Business Update (GlobeNewswire)
Nov-13-23 09:00AM	Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023 (GlobeNewswire)
Oct-26-23 04:22PM	Iridex to Report Third Quarter Financial Results on November 14, 2023 (GlobeNewswire)
Aug-29-23 04:05PM	Iridex Announces Strategic Review to Unlock Shareholder Value (GlobeNewswire) +6.57% +13.70%
Aug-11-23 06:59AM	Q2 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -28.25%
Aug-10-23 06:30PM	Iridex (IRIX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:23PM	Iridex: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Iridex Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Aug-09-23 08:46AM	We Think IRIDEX (NASDAQ:IRIX) Needs To Drive Business Growth Carefully (Simply Wall St.)
Jul-27-23 04:05PM	Iridex to Report Second Quarter Financial Results on August 10, 2023 (GlobeNewswire)
Jun-21-23 05:00AM	Zacks Industry Outlook Highlights IPG Photonics and IRIDEX (Zacks)
Jun-20-23 12:25PM	2 Laser Systems Stocks to Buy in a Prospering Industry (Zacks)
Jun-08-23 07:06AM	IRIDEX Corporation's (NASDAQ:IRIX) Price Is Right But Growth Is Lacking (Simply Wall St.)
May-18-23 08:50AM	Iridex (IRIX) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
May-12-23 06:37AM	Q1 2023 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents)
May-11-23 06:05PM	Iridex (IRIX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:56PM	Iridex: Q1 Earnings Snapshot (AP Finance)
04:05PM	Iridex Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-27-23 04:05PM	Iridex to Report First Quarter Financial Results on May 11, 2023 (GlobeNewswire)
Apr-21-23 02:37PM	10 Best Humane Stocks to Buy Now (Insider Monkey)
Apr-12-23 07:00AM	Multiple insiders bought IRIDEX Corporation (NASDAQ:IRIX) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Mar-13-23 01:58AM	IRIDEX Corporation (NASDAQ:IRIX) Q4 2022 Earnings Call Transcript (Insider Monkey) +5.10%
Mar-10-23 06:27AM	Q4 2022 IRIDEX Corp Earnings Call (Thomson Reuters StreetEvents) -9.07%
Mar-09-23 05:55PM	Iridex (IRIX) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Iridex Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-07-23 04:05PM	Iridex to Present at the 35th Annual Roth Conference (GlobeNewswire)
Mar-02-23 09:00AM	Iridex Introduces New Research and Showcases Five Events at the AGS Meeting (GlobeNewswire)
07:26AM	We're Keeping An Eye On IRIDEX's (NASDAQ:IRIX) Cash Burn Rate (Simply Wall St.)
Feb-23-23 04:05PM	Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023 (GlobeNewswire)
Jan-10-23 04:05PM	Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022 (GlobeNewswire) +6.10%
Dec-06-22 05:07PM	Iridex to Participate in Fireside Chat with Stifel Equity Research (GlobeNewswire)
Nov-13-22 07:48AM	IRIDEX Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-10-22 06:35PM	Iridex (IRIX) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Iridex Announces Record Third Quarter 2022 Financial Results (GlobeNewswire)
Nov-03-22 06:53AM	A number of insiders bought IRIDEX Corporation (NASDAQ:IRIX) stock last year, which is great news for shareholders (Simply Wall St.)
Oct-27-22 04:05PM	Iridex to Report Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Sep-29-22 04:05PM	Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022 (GlobeNewswire)
Sep-23-22 07:55AM	We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely (Simply Wall St.)

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dizon Romeo R	Chief Financial Officer	Nov 19 '25	Buy	0.96	1,000	960	82,976	Nov 20 11:42 AM
Dizon Romeo R	Chief Financial Officer	Nov 18 '25	Buy	0.94	2,133	2,005	81,976	Nov 19 09:05 AM
MOORE WILLIAM M	Director	Nov 14 '25	Buy	0.97	28,157	27,245	228,831	Nov 18 02:56 PM
MOORE WILLIAM M	Director	Nov 17 '25	Buy	0.97	21,843	21,087	250,674	Nov 18 02:56 PM
Dizon Romeo R	Chief Financial Officer	Nov 17 '25	Buy	0.96	3,124	2,999	79,843	Nov 18 09:58 AM
Dizon Romeo R	Chief Financial Officer	Nov 14 '25	Buy	0.88	14,769	12,997	76,719	Nov 17 09:05 AM
Dizon Romeo R	Chief Financial Officer	Sep 12 '25	Buy	1.36	1,450	1,975	61,950	Sep 15 01:26 PM
Dizon Romeo R	Chief Financial Officer	Sep 11 '25	Buy	1.35	1,250	1,682	60,500	Sep 12 11:36 AM
Dizon Romeo R	Chief Financial Officer	Sep 10 '25	Buy	1.34	1,500	2,010	59,250	Sep 11 11:30 AM
Dizon Romeo R	Chief Financial Officer	Sep 09 '25	Buy	1.37	1,500	2,055	57,750	Sep 10 11:36 AM
Dizon Romeo R	Chief Financial Officer	Sep 08 '25	Buy	1.40	500	700	56,250	Sep 09 11:38 AM
Dizon Romeo R	Chief Financial Officer	Sep 05 '25	Buy	1.35	1,000	1,350	55,750	Sep 08 11:42 AM
Dizon Romeo R	Chief Financial Officer	Sep 04 '25	Buy	1.36	1,125	1,531	54,750	Sep 05 10:59 AM
Dizon Romeo R	Chief Financial Officer	Sep 03 '25	Buy	1.36	625	850	53,625	Sep 04 11:39 AM
Dizon Romeo R	Chief Financial Officer	Sep 02 '25	Buy	1.34	625	838	53,000	Sep 02 09:35 PM
Dizon Romeo R	Chief Financial Officer	Aug 29 '25	Buy	1.37	625	856	52,375	Aug 29 06:17 PM
Dizon Romeo R	Chief Financial Officer	Aug 28 '25	Buy	1.35	1,005	1,356	51,750	Aug 28 09:37 PM
Dizon Romeo R	Chief Financial Officer	Aug 27 '25	Buy	1.28	1,000	1,283	50,745	Aug 27 08:56 PM
Dizon Romeo R	Chief Financial Officer	Aug 26 '25	Buy	1.26	1,000	1,258	49,745	Aug 27 11:48 AM
Dizon Romeo R	Chief Financial Officer	Aug 25 '25	Buy	1.25	1,000	1,245	48,745	Aug 26 11:48 AM
Dizon Romeo R	Chief Financial Officer	Aug 22 '25	Buy	1.22	1,000	1,220	47,745	Aug 25 11:55 AM
Dizon Romeo R	Chief Financial Officer	Aug 21 '25	Buy	1.25	2,000	2,490	46,745	Aug 22 12:06 PM
Dizon Romeo R	Chief Financial Officer	Aug 20 '25	Buy	1.18	1,000	1,184	44,745	Aug 21 02:19 PM
Dizon Romeo R	Chief Financial Officer	Aug 19 '25	Buy	1.17	3,000	3,499	43,745	Aug 20 01:21 PM
MOORE WILLIAM M	Director	Aug 18 '25	Buy	1.18	12,024	14,229	200,674	Aug 19 07:08 PM
Dizon Romeo R	Chief Financial Officer	Aug 18 '25	Buy	1.18	1,500	1,767	40,745	Aug 19 06:27 PM
Dizon Romeo R	Chief Financial Officer	Aug 15 '25	Buy	1.17	1,500	1,755	39,245	Aug 18 06:15 PM
MOORE WILLIAM M	Director	Jun 13 '25	Buy	0.97	20,000	19,372	188,650	Jun 16 01:44 PM
Mercer Patrick	President and CEO	Jun 13 '25	Buy	0.96	250	240	386,730	Jun 13 02:43 PM
MOORE WILLIAM M	Director	Jun 12 '25	Buy	0.97	20,000	19,494	168,650	Jun 13 01:28 PM
MOORE WILLIAM M	Director	Jun 11 '25	Buy	0.96	10,000	9,627	148,650	Jun 13 01:28 PM
Dizon Romeo R	Chief Financial Officer	Jun 11 '25	Buy	0.96	245	236	15,245	Jun 11 08:16 PM
Dizon Romeo R	Chief Financial Officer	Jun 09 '25	Buy	0.99	500	495	14,665	Jun 10 06:32 PM
Dizon Romeo R	Chief Financial Officer	Jun 10 '25	Buy	0.98	335	327	15,000	Jun 10 06:32 PM
Dizon Romeo R	Chief Financial Officer	Jun 06 '25	Buy	0.97	1,500	1,455	14,165	Jun 06 07:07 PM
Dizon Romeo R	Chief Financial Officer	Jun 02 '25	Buy	1.00	100	100	12,565	Jun 03 07:18 PM
Dizon Romeo R	Chief Financial Officer	Jun 03 '25	Buy	0.99	100	99	12,665	Jun 03 07:18 PM
Dizon Romeo R	Chief Financial Officer	May 29 '25	Buy	0.98	200	197	12,465	May 29 08:10 PM
Dizon Romeo R	Chief Financial Officer	May 28 '25	Buy	0.95	200	190	12,265	May 28 07:28 PM
Dizon Romeo R	Chief Financial Officer	May 27 '25	Buy	1.00	100	100	12,065	May 27 08:01 PM
Dizon Romeo R	Chief Financial Officer	May 23 '25	Buy	1.00	100	100	11,965	May 27 05:21 PM
Dizon Romeo R	Chief Financial Officer	May 22 '25	Buy	1.00	200	201	11,865	May 22 05:05 PM
MOORE WILLIAM M	Director	May 14 '25	Buy	1.10	15,000	16,506	136,150	May 16 01:38 PM
MOORE WILLIAM M	Director	May 15 '25	Buy	1.00	2,500	2,502	138,650	May 16 01:38 PM
Dizon Romeo R	Chief Financial Officer	May 14 '25	Buy	1.10	460	506	11,665	May 15 05:20 PM
Dizon Romeo R	Chief Financial Officer	May 13 '25	Buy	1.11	1,305	1,451	11,205	May 13 05:35 PM
Dizon Romeo R	Chief Financial Officer	May 12 '25	Buy	1.16	100	116	9,900	May 12 05:53 PM
Dizon Romeo R	Chief Financial Officer	May 09 '25	Buy	1.15	100	115	9,800	May 09 04:46 PM
Dizon Romeo R	Chief Financial Officer	May 08 '25	Buy	1.15	100	115	9,700	May 08 05:48 PM
Dizon Romeo R	Chief Financial Officer	May 07 '25	Buy	1.15	193	222	9,600	May 07 06:29 PM
Dizon Romeo R	Chief Financial Officer	May 06 '25	Buy	1.17	200	235	9,407	May 06 05:51 PM
Dizon Romeo R	Chief Financial Officer	May 05 '25	Buy	1.19	200	237	9,207	May 05 06:34 PM
MOORE WILLIAM M	Director	Apr 29 '25	Buy	1.21	19,710	23,784	121,150	Apr 30 03:16 PM
MOORE WILLIAM M	Director	Apr 28 '25	Buy	1.24	290	360	101,440	Apr 30 03:16 PM
Dizon Romeo R	Chief Financial Officer	Apr 29 '25	Buy	1.23	3,907	4,807	9,007	Apr 29 07:42 PM
Dizon Romeo R	Chief Financial Officer	Apr 28 '25	Buy	1.28	2,625	3,362	5,100	Apr 28 06:35 PM
Mercer Patrick	President and CEO	Apr 28 '25	Buy	1.29	7,500	9,705	400,790	Apr 28 05:18 PM
Mercer Patrick	President and CEO	Apr 24 '25	Buy	1.15	46	53	393,290	Apr 28 05:18 PM
Dizon Romeo R	Chief Financial Officer	Apr 25 '25	Buy	1.18	975	1,150	2,475	Apr 25 02:53 PM
Shuda Scott	Director	Apr 24 '25	Buy	1.20	21,457	25,748	129,523	Apr 25 11:39 AM
Dizon Romeo R	Chief Financial Officer	Apr 24 '25	Buy	1.20	500	600	1,500	Apr 24 05:51 PM
Dizon Romeo R	Chief Financial Officer	Apr 23 '25	Buy	1.11	500	555	1,000	Apr 24 05:51 PM
HUSS BEVERLY A	Director	Apr 23 '25	Buy	1.22	25,900	31,500	92,639	Apr 24 04:21 PM
MOORE WILLIAM M	Director	Apr 22 '25	Buy	1.08	10,000	10,831	101,150	Apr 23 07:10 PM
MOORE WILLIAM M	Director	Apr 21 '25	Buy	1.05	10,000	10,540	91,150	Apr 23 07:10 PM
Dizon Romeo R	Chief Financial Officer	Apr 21 '25	Buy	1.05	500	525	500	Apr 22 01:00 PM
Grove Robert Earle	Director	Apr 21 '25	Proposed Sale	0.92	8,000	7,372		Apr 21 04:48 PM
Grove Robert Earle	Director	Apr 17 '25	Proposed Sale	0.92	8,000	7,335		Apr 17 05:24 PM

Black Swan Sale

50% Off Elite

PLUR

TBRG

DGICA

SHBI

FOSL

MPB

INTT

COSM

ITRM

IRIX

Upgrade your FINVIZ experience